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ABSTRACT
A diverse community of bacteria populates the mammalian gastrointestinal tract. These
populations exist in a balance with the host assisting with critical functions, particularly the
metabolism of intractable fibers and immune modulation. Disruption of this balance can lead to
diseases such as infection, inflammatory bowel syndrome, and obesity. Common symptoms
include chronic pain, chronic inflammation, and altered metabolism. Several taxonomic
classifications of bacteria have been associated with these diseases, but recent studies have
indicated that these findings are not always statistically valid. An explanation for this is that
microbial communities between individuals and even across time can vary substantially even
when the individuals have a similar health status. Microbial function, however, is a promising
arena to study disease scenarios. Omics methods, which measure the entire gene content of a
community, are a particularly powerful set of techniques with which to analyze the potential and
active function of microbiome communities. Metaproteomics detects and quantifies proteins
directly from environmental samples and can be used to measure gut microbiome functional
activity. This dissertation applied the use of LC-MS/MS based metaproteomics and metagenomic
sequencing to study gut microbiome function in adult humans with Crohn’s disease, preterm
infants with necrotizing enterocolitis, and obese and morphine treated mice. Substantial
variability across time and individuals was observed at the discrete protein sequence level;
however, specific functions such as reactions and metabolic modules were shown to be more
conserved. Fully connected metabolic networks and pathways were reconstructed from these
metaproteomes, and specific metabolic reactions are shown to be affected by necrotizing colitis,
diet-induced obesity, and morphine. This dissertation makes a major step forward by showing
discrete metabolic reactions can be effectively analyzed using metaproteomic data.
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OVERVIEW OF THE MICROBIOME WITH AN EMPHASIS ON GUT
MICROBIOME FUNCTION

Text adapted from:
Blakeley-Ruiz, J.A., Erickson, A.R., Cantarel, B.L., Xiong, W., Adams, R., Jansson, J.K., Fraser,
C.M., Hettich, R.L. Metaproteomics reveals persistent and phylum-redundant metabolic
functional stability in adult human gut microbiomes of Crohn’s remission patients despite
temporal variations in microbial taxa, genomes, and proteomes. Microbiome 7, 18 (2019).
https://doi.org/10.1186/s40168-019-0631-8
Blakeley-Ruiz, J. A., McClintock, C. S., Lydic, R., Baghdoyan, H. A., Choo, J. J., & Hettich, R.
L. Combining integrated systems-biology approaches with intervention-based
experimental design provides a higher-resolution path forward for microbiome research.
Behavioral and Brain Sciences, 42 (2019). DOI:10.1017/S0140525X18002911
J. Alfredo Blakeley-Ruiz's contributions include data analysis, literature review, writing of the
original manuscript, revision, and response to reviewers.

1.1 Overview of the human microbiome
Text adapted from Blakeley-Ruiz et al. 2019. Microbiome 7, 18.
The human body hosts a dynamic ecosystem of microbial organisms that form an integral
part of the overall health maintenance of the host (Clemente et al. 2012). This microbiota
comprises several similar but distinct niches spread out across every surface and cavity of the
body, including the skin, nose, mouth, genital tract, and gut, where they perform similar but
distinct functions (The Human Microbiome Project 2012). Initial estimates suggested an
approximate 10 to 1 ratio of bacteria to human cells in the human body using back-of-theenvelope calculations; however, since then, a more conservative estimate of 1.3 bacterial cells
for every human somatic cell has been calculated (Sender et al. 2016, Gilbert et al. 2018). The
microbial population of any one person can contain more than 1000 distinct bacterial species,
expanding the genetic repertoire of the human body from approximately 20,000 genes to well
over a million (Locey and Lennon 2016). Many of these genes, however, represent redundant
functions. A microbiome that has a healthy interaction with the host, termed “eubiosis,” has been
credited with assisting the host with critical functional roles, including expanded metabolism,
pathogen defense, immune development, and immune modulation (Koropatkin et al. 2012, den
Besten et al. 2013, Smith et al. 2013). A breakdown of this healthy interaction, termed
“dysbiosis,” correlates with unhealthy phenotypes such as obesity, allergies, chronic pain, and
inflammation (Bisgaard et al. 2011, Ridaura et al. 2013, Rea et al. 2017).
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The largest microbial population in terms of biomass is found in the gastrointestinal tract
(Rosner 2014). The gut microbiota plays a critical role in assisting the host with the metabolism
of indigestible food products and immune modulation (den Besten et al. 2013, Sun et al. 2017).
Fermentation products produced by the gut microbiota, including short-chain fatty acids, lie at
the intersection of human host-microbiota interactions. These fermentation products, particularly
butyrate, propionate, and acetate, represent major sources of energy for the host especially in
colonocytes (McNeil 1984, Donohoe et al. 2011), and play a role in host immune modulation,
health, and disease (Vinolo et al. 2011, Lin et al. 2012, Smith et al. 2013, Iraporda et al. 2015).
Distinct microbial niches populate the different regions of the gastrointestinal tract
(Suchodolski et al. 2005). Starting in the small intestine, the diversity of the microbiome
increases as it progresses down the intestinal tract with the most diverse population present in the
distal colon. Although distinct microbes populate different regions of the gastrointestinal tract,
fecal samples capture a representative sampling of the entire gastrointestinal tract (Eckburg et al.
2005).

1.2 Composition of the gut microbiome
In total, the species that make up the human microbiome represent phyla from all
domains of life, including archaea, fungi, bacteria, and viruses. Bacteria remain the most well
studied because 16S rRNA and whole-genome sequencing methods favor bacteria (Goodrich et
al. 2014); however, use of the internal transcribed spacer region (ITS), as well as advances in
metagenomic analysis methods (Pride et al. 2012, Schoch et al. 2012, West et al. 2018), promises
more representation of fungi and viruses in future studies. Among bacteria, the majority of
species in the microbiome come from the phyla Firmicutes, Bacteroidetes, Proteobacteria, and
Actinobacteria, with Firmicutes and Bacteroidetes making up the highest proportion. Early and
more recent studies have suggested that a higher proportion of Firmicutes relative to
Bacteroidetes may be indicative of several microbiome-related diseases; however, more recent
meta-analyses challenge these findings (Sze and Schloss 2016). A variety of host and
environmental factors affect the composition of an individual’s gut microbiome and its similarity
to others.
At birth, microorganisms rapidly colonize the gut within the first few days of life. Early
in life, the microbiome can change substantially in composition over time, sometimes having a
2

more different composition across time than between individuals (Brown et al. 2018). Over time,
the microbiome proceeds through several successions increasing in diversity until it plateaus at
around 2-3 years of life, becoming more similar to an adult gut microbiome (Yatsunenko et al.
2012, Yassour et al. 2016). During this colonization period, the microbiome modulates the
immune system, making it accustomed to commensal bacteria. For example, the diversity of the
microbiome during this colonization period modulates the levels of inflammatory cytokines
(Cahenzli et al. 2013). A variety of factors can affect this development, including birth mode,
antibiotic use, and diet. A vaginal birth microbiome tends to end up similar to the mother’s
microbiome, while the caesarian tends to start more similar to the skin microbiome and ends up
distinct from a vaginal delivery microbiome (Dunn et al. 2017, Wampach et al. 2017). Breast
milk tends to favor Bifidobacteria and Lactobacillus. In contrast, formula tends to favor
Bacteroides and Clostridium (Arrieta et al. 2014), and transitions between colonization
successions appear to be associated with the introduction of solids (Fallani et al. 2011).
Antibiotic use, in particular, delays the colonization of certain bacteria like Bacteroidetes and
correlates with asthma and autoimmune diseases later in life (Arrieta et al. 2014).
After the colonization period, the gut microbiome becomes more personalized, with
individual gut microbiota being more similar across time than between individuals. It appears,
however, that some individual gut microbiomes change more over time in composition than
others (Flores et al. 2014). How much the microbiome changes may also be disease-related
(Halfvarson et al. 2017). The diversity of the gut microbiome decreases in old age, while the
proportion of opportunistic bacteria increases (Nagpal et al. 2018). After the colonization period,
the gut microbiome also becomes similar to the mother’s microbiome, suggesting a genetic
component to the composition of the microbiota. Monozygotic twins have a significantly more
similar microbiome (Goodrich et al. 2014). Several studies used twins to account for this genetic
variation; however, disease state has been shown to have a greater effect on the microbiome
(Erickson et al. 2012, Ridaura et al. 2013). Much of this genetic effect could be driven by cohabitation. Non-related partners have significantly similar microbiomes to each other (DillMcFarland et al. 2019), and the addition of animals appears to increase this similarity. Families
with dogs have more similar microbiomes than those that do not (Song et al. 2013). Geography
appears to have an impact on the composition of the gut microbiome. People from South
America have distinct gut microbiomes from those in North America (Yatsunenko et al. 2012),
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and rural Indians have distinct microbiomes from urban Indians (Das et al. 2018). Differences in
diet between the communities may drive much of this geography-based difference. Diet plays a
significant role in the composition of the gut microbiome. Westernized diets substantially alter
the gut microbiome (Bisanz et al. 2019), and a transition from an animal-based diet to a
vegetarian diet can alter the gut microbiome within a single day (David et al. 2013).
Many diseases interrelate with the composition of the gut microbiome. A gnotobiotic
mouse model showed that an obese microbiome introduced to a lean mouse could trigger an
obese phenotype; however, obesity is a bit more complex than a singular entity (Ridaura et al.
2013). Diet-induced obesity alters the gut microbiome distinctly and more significantly than
genetically induced obesity, implying that though an obese microbiome can cause an obese
phenotype, the underlying factors that cause obesity can also alter the microbiome (Pfalzer et al.
2015). Chronic gastrointestinal diseases such as Crohn’s disease, irritable bowel syndrome, and
inflammatory bowel syndrome correlate with distinctly altered microbiomes as well (Gilbert et
al. 2018). Twins discordant for these diseases have been shown to have as different microbiomes
from each other as non-twins, indicating that the effect of these diseases on the microbiome is
more potent than any genetic effect and that factors other than genetics also play a role in the
development of these diseases (Erickson et al. 2012). Crohn’s disease in particular is associated
with intolerance of vegetables (Ballegaard et al. 1997). This intolerance implies a disfunction in
microbial metabolic function since vegetables are typically associated with a healthy microbiota.
Though the most abundant phyla appear to be consistent at lower taxa, the variation
across time and individuals can be quite substantial. The set of species present in the gut
microbiome can be completely different between two individuals, and core species within an
individual can be as low as 5% (Gilbert et al. 2018). In one of the early microbiome studies, 70%
of the species detected were unique to a single individual (Ley et al. 2006). Microbial
composition tends to be more consistent within an individual over time than across individuals,
suggesting a personalized microbiome. Despite this personalization, the microbiome can be more
subject to variation over time in some individuals versus others, and at least one study found this
increased variance to be associated with disease (Halfvarson et al. 2017). Perturbations to the gut
microbiome can lead to significant changes in composition within a single day, and more
prolonged perturbations can have long term effects. With this much variation, it can be
challenging to trace diseases associated with the microbiome to a specific set of taxa. The
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functionality of the microbiome, however, is more consistent and may be a more tractable space
in which to study microbiome associated effects.

1.3 Interface between the microbiome and the host
The gut microbiome plays critical roles in metabolism, immune modulation, and
pathogen defense. Metabolically its primary role involves degrading dietary products into
products that can be used by the host for energy. Typically the human genome has the enzymes
needed to degrade starch, lactose, and sucrose but cannot degrade more complex plant fibers like
pectins, xylans, and hemicelluloses (Koropatkin et al. 2012). In the gut, particularly in the colon,
the microbiome degrades these glycans into sugars and ferments them via the typical anaerobic
pathways. These pathways yield a variety of products, with short-chain fatty acids being the most
well studied (den Besten et al. 2013). The most abundant short-chain fatty acids in the gut are
acetate, propionate, and butyrate, with acetate being the most abundant. Approximately 95% of
short-chain fatty acids produced by bacteria are rapidly taken up by the host (Topping and
Clifton 2001). These short-chain fatty acids account for the majority of the energy needed by
colonocytes (Donohoe et al. 2011). Overall these short-chain fatty acids have been suggested to
account for 10% of the host’s energy in western diets, with the hypothesis that this could be
higher in more plant-based diets (McNeil 1984). Diet can impact this process. Westernized diets
that are high in fat at the expense of fiber decrease the amount of short-chain fatty acids
produced (Jakobsdottir et al. 2013). Interestingly, low in fiber diets diet can cause certain
bacteria, like Bacteroides thetaiotaomicron, to transition away from digesting diet fibers and
towards digesting the intestinal mucosal interface, which may be a significant factor in the
disruption of the mucosal layer leading to disease (Desai et al. 2016). Production of short-chain
fatty acids is mutliphyletic, and the extent to which different bacteria perform this function
remains to be fully understood (Parada Venegas et al. 2019).
A mucosal layer separates the epithelial lining of the intestine from the gut microbiome
and other potentially harmful substances. In the colon, there are two mucosal layers, an
impenetrable layer that protects the epithelial cells and a second layer that is populated by
specific bacteria (Johansson et al. 2013). The gut microbiome interacts with the host at this
interface. Glycoproteins called mucins, produced by goblet cells, make up the bulk of the
mucosal layer (Johansson 2012). Mucins form a gel-like layer that permits beneficial molecules
5

like sugars to be taken up by the host but prevents harmful substances, such as antigens and
microbes, from interfacing with the epithelial cells.
Glycans made up of several different sugars, including acetylgalactosoamine,
acetylglucosamine, acetylneuraminate, fucose, and galactose, glycosylate mucins at serine and
threonine residues (Holmen Larsson et al. 2013, Marcobal et al. 2013). Several bacteria can
degrade these glycans for energy (Berry et al. 2013). Specifically, Bacteroides thetaiatamicron
and Akkermansia muciniphila have been well-documented to degrade mucin; however, it seems
Akkermansia muciniphila uses mucin as its primary form of energy (Van Herreweghen et al.
2017), while Bacteroides thetaiatamicron is more opportunistic with the ability to degrade both
dietary products and mucin (Sonnenburg et al. 2005). Other bacteria have been shown to forage
mucin as well (Berry et al. 2013); however, many of the mechanisms by which the microbiome
harvests mucin and the extent to which different microbes do this remains poorly understood.
Proper formation of the mucosal layer requires the presence of the microbiome. Germ-free mice
have been shown to have a more permeable mucosal layer, which can be recovered after long
term colonization by the microbiome (Johansson et al. 2015). Specific bacteria have been shown
to be associated with the production of mucin. Akkermansia muciniphila correlates with an
increase in sulfated mucins and negatively correlates with ulcerative colitis (Earley et al. 2019).
Short-chain fatty acids produced by bacteria, particularly butyrate and propionate, have been
shown to increase mucin production (Burger-van Paassen et al. 2009). Thus, it may be beneficial
for certain bacteria to feed on the mucosal layer but harmful for others.
Many of the primary gut microbiome diseases exhibit disruption of the mucosal layer as a
symptom, including obesity, ulcerative colitis, Crohn’s disease, and necrotizing enterocolitis
(NEC) (Dorofeyev et al. 2013, Jiang et al. 2013, Gulhane et al. 2016). Disruption of the mucosal
layer correlates with increased gut permeability and inflammation, which represent the hallmarks
of these diseases (Poret et al. 2018, Ravisankar et al. 2018). Short-chain fatty acids and likely
other bacteria-derived metabolites are associated with inflammation suppression, thus creating a
link between microbial metabolism, the formation of the mucosal layer, and chronic
inflammation (Parada Venegas et al. 2019). Increasing understanding of the details behind
microbial metabolism is critical for ameliorating these diseases.
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1.4 Methods for looking at gut microbiome function
Text adapted from Blakeley-Ruiz et al. 2019 Behavioral and Brain Sciences, 42.
Deriving a more detailed understanding of how the metabolic activities of microbial
communities affect host physiology requires an expanded experimental design. Many studies
have demonstrated that microbial community composition varies across individuals, but clusters
as a function of age, geography, diet, cohabitation, and health (The Human Microbiome Project
2012, Yatsunenko et al. 2012, David et al. 2013, Song et al. 2013, Halfvarson et al. 2017). This
implies that all these factors have an impact on the host’s microbial composition, and that
replicating the composition of the microbiome without exact replication of experimental
conditions (e.g., individuals, laboratories, diet) is complicated. This is a formidable problem even
with large sample sizes. This limitation suggests that there is less of a reproducibility crisis (Sze
and Schloss 2016), and more of a need to design more elaborate and appropriate experiments
(Knight et al. 2018).
There is evidence that despite significant variation in microbial composition, broad
biological function appears to remain similar (The Human Microbiome Project 2012). Thus,
microbiome research will be greatly propelled by experimental designs that combine intervention
studies with systems-biology techniques that seek to characterize overall microbiome function.
Currently, four “omics” techniques capture “detailed” molecular-level information about a
microbial community: whole community genome (metagenome) sequencing (The Human
Microbiome Project 2012), metatranscriptome sequencing (Jorth et al. 2014), metaproteome
identification (Erickson et al. 2012), and metabolome characterization (Karu et al. 2018). Each of
these techniques has advantages and limitations. However, a combination of these techniques
should lead to a high-resolution portrayal of microbial function and potentially microbial
metabolic reconstruction at the community level.
Whole metagenomic sequencing provides a backbone for investigating microbiome
function via the creation of a composite gene-catalog. Initially, reference sequence databases
were used to characterize the taxonomy and function of a microbial community (The Human
Microbiome Project 2012, Stewart et al. 2018), but were limited by the range of known reference
genomes, and functional ortholog databases. Advancements in the understanding of genomic
features allow combining tetranucleotide frequency with sequence coverage to bin the results
from metagenomic assemblies into metagenome assembled genomes (MAGs) de-novo (Kang et
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al. 2019). This approach provides a set of low to high-quality draft genomes, which can provide
subspecies information about the gene repertoire of a microbial community (Brown et al. 2018).
Although metagenomic sequencing allows categorizing a set of genes into their respective
taxonomy and predicting their function, metagenomics is limited to only predicting potential
function because it contributes no information about the actual translation of genes into proteins.
Although the laboratory technique behind metatranscriptomics is more similar to
metagenomic sequencing, both metatranscriptomics and metaproteomics explore a similar
question: which predicted genes are being transcribed and subsequently translated into proteins?
Transcriptome sequencing identifies genes that are being transcribed into RNA and generally
produces more total identifications, while LC-MS/MS based metaproteomics ultimately
identifies proteins, thus providing confirmation that a metagenomics predicted gene is translated
into protein (Erickson et al. 2012, Jorth et al. 2014). Although the number of identified proteins
tends to be fewer than transcripts, it is unclear how many proteins microbes utilize in a
community. Strides have been made by integrating MAGs with metaproteomes in lower
diversity communities, but much work remains to answer this question (Xiong et al. 2017).
Theoretically, metaproteomics should provide a better connection to phenotype since functional
products of gene expression are measured.
Gas (GC) and liquid (LC) chromatography paired with mass spectrometry provide an
approach for detecting metabolites within microbial communities (Karu et al. 2018). Although
these molecules are difficult to connect to their organism of origin without complementary gene
information, metabolomics provides a framework to evaluate metabolic hypotheses derived from
genetic or protein information. Enzyme-to-compound databases, such as Kyoto Encyclopedia of
Genes and Genomes (KEGG) (Kanehisa et al. 2016) and MetaCyc (Caspi et al. 2018), can
provide annotation of recognized genes with an enzyme identifier, thereby connecting specific
taxa, genes, and proteins to specific molecular functions at the compound level. Ultimately, these
features can create a framework by which metabolomic data can be integrated with microbiome
data.
Using constrained experimental conditions combined with specific hypothesis-driven
intervention, researchers can connect the power of cause-and-effect experimental design with
integrated “omics” to characterize the microbiome under different interventions. Time-course
studies would be ideal, as the sample subject can function as its own internal control. Eventually,
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as the community of investigators transitions into the next phase of microbiome research, general
intervention-based studies and broad characterization of microbial composition at the population
level will no longer be sufficient to provide novel insights into the gut microbiome. Holistic
metabolic modeling through systems-biology measurements of individual microbiomes
combined with intervention-based experimental design provides a path forward.

1.5 Overview of dissertation
This dissertation seeks to advance microbiome research by exploring the use of
metaproteomics to look at specific metabolic functions. The most specific function possible is
the individual reaction an enzyme catalyzes. Databases such as MetaCyc and KEGG have a
wealth of data associating protein sequences to the reactions they catalyze (Kanehisa et al. 2016,
Caspi et al. 2018). By annotating genes in a metagenome with this data, the potential metabolic
functions of a microbial community can be explored, while retaining a link to the genome of
origin. Metagenomics, however, only measures the predicted genes of a community with no
knowledge about whether that gene is being transcribed or translated into protein or even if it can
be translated into protein. Metaproteomics adds another layer of information by detecting the
most abundant genes that have been translated into proteins. In this dissertation, it is shown that
although individual proteins can be highly varied between conditions, the specific functions that
they code for are much more conserved and can be used to explore shifts in host and microbial
metabolic function due to perturbation. This dissertation is divided into six chapters, including
this introductory chapter. The chapters include one methodological chapter, three experimental
chapters, and a concluding chapter.
Chapter 2 provides an overview of many of the methodological considerations needed to
detect proteins in environmental samples. This chapter covers all the steps from preparing
samples to detecting proteins using a mass spectrometer. Some specific environmental
considerations are included, such as the preparation of protein databases, and some
recommendations for assigning taxonomy and function to proteins are mentioned at the end.
Chapter 3 explores the metaproteomes of five Crohn’s disease patients after resection
surgery. Each patient had five samples collected throughout a single year. The purpose of this
study was to explore the stability of the metaproteome across time and individuals. This included
determining how similar metaproteomes were across time and individuals, whether the same was
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true for the functions inferred from the metaproteomes, and how redundant those functions were
across taxa.
Chapter 4 represents a natural progression from chapter 3 by using samples taken from
preterm infants. In this study, it was explored whether the specific reactions that annotate the
metaproteome were more conserved across time and samples than the proteins themselves and
whether these reactions could be connected by the compounds they catalyze to build fully
connected metabolic networks. These reactions could be used to identify functional differences
between infants that developed necrotizing enterocolitis and those that did not.
The goal of Chapter 5 was to see if morphine differentially alters the microbiome of mice
with different kinds of obesity from a taxonomical and functional perspective. In this chapter, the
taxonomical composition of the gut microbiome was analyzed by 16S rRNA sequencing and
genome resolved metagenomics, and the function was analyzed using metaproteomics to infer
detailed metabolic functions as described in Chapter 4.
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2

TECHNICAL CONSIDERATIONS FOR USING METAPROTEOMICS
TO EXPLORE GUT MICROBIOME FUNCTION

2.1 Introduction
The large-scale detection of the complete suite of proteins from environmental samples,
termed metaproteomics, is an extension of mass spectrometry-based proteomics where proteins
are extracted directly from an environmental sample instead of a microbial isolate or
multicellular tissue sample (Wilmes and Bond 2004). In proteomics, proteins isolated from a
sample are digested into peptides, separated via liquid chromatography, measured by mass
spectrometry, and detected by matching resultant mass spectra to theoretical spectra derived
from a protein sequence database (Figure 2.1). Ultimately, the goal of a proteomics experiment is
to maximize the number of quantifiable proteins detectible with reasonable confidence and
minimal ambiguity. In metaproteomics, there is the additional challenge of inferring the function
and taxonomy of detected proteins. This chapter will discuss the main elements needed to detect
proteins and infer their function in gut microbiomes. Many of the items in this chapter can be
generalized to the analysis of other environmental samples, and as such most of the chapter is
relatively general in terms of sample origin. This chapter also contains some preliminary
analyses that were useful in defining the methods for the later chapters but were not included
there.

2.2 Preparation of samples for detection by mass spectrometry
The main purpose of analyzing an environmental sample by metaproteomics is to
characterize the composition and/or function of a specific type of microbial community, like a
gut or soil microbiome. The problem is that even though a microbial community is likely to have
a typical composition in terms of phyla, the composition of a microbial community can change
across habitats, space within a habitat, and time. For example, in the gut >70% of the microbial
species can be different between individuals (Ley et al. 2006), the composition of the gut
microbiome can alter within a single day (David et al. 2013), and the community at the start of
the colon can be distinct from the community of at the end of the colon (Eckburg et al. 2005).
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Figure 2.1: Worflow for taking DNA and protein from a fecal sample and processing it in the mass spectrometer or
sequencer

This implies that it is impossible to know the composition of a specific gut microbiome a priori
and that specific care needs to be taken in the selection of samples before the extraction of
proteins.
2.2.1 Considerations for samples selection
Eckburg et al. showed that the composition of the microbiome in the colon changes
spatially, increasing in diversity from beginning to end; however, they also found that fecal
material represented the best overall average of the gut microbiome (Eckburg et al. 2005). This
implies that for studying the whole gut microbiome, fecal material is the best sample; however, if
the study question is more localized, a more targeted sampling is needed. For example, Zhang et
al. used mucosal luminal interface aspirates to compare three separate parts of the colon, both
with and without inflammation, providing a better understanding of the localized effects of
inflammatory bowel disease (Zhang et al. 2018). In this dissertation, the goal was to look at the
overall gut microbiome, so fecal samples were used.
An additional consideration is how the sample is collected. The gut microbiome exists in
an anaerobic environment (Flint et al. 2012); however, as soon as fecal material leaves the body,
it becomes exposed to an aerobic environment. Since some of the bacteria in the gut are
facultative anaerobes while others are strict anaerobes, this creates some concern that the
microbial composition of the sample will change the more time passes between a bowel
movement and the processing of the sample. Some studies have shown that for population
profiling, the community does not change much within the first 24 hours (Tedjo et al. 2015);
however, what may be true for population profiling may not be correct for functional analysis
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using proteins. Exposure to an aerobic environment automatically alters the metabolic processes
available, and the impact of the host on the microbiome is no longer retained. One solution to
this is to inactivate the microbiome using a chemical solution such as ethanol (Song et al. 2016).
This approach is particularly popular for field studies, where access to freezers is limited (Tung
et al. 2015). In the lab and the clinical setting, freezing is more common. For adult humans, the
typical procedure is self-collection at home, followed by immediate freezing and shipment to the
collection center where the samples are placed at -80⸰C within 24 hours. This was done in
chapter 3. With preterm infants, the infants are in intensive care, so collection by professionals
and freezing shortly after is possible. This was done in chapter 4. With mice, samples are
typically collected in metabolic cages over 24 hours, this raises some concern that the samples
will have been exposed to an aerobic environment for too long. In the case of chapter 5, fecal
material was extracted surgically directly from the colon.
2.2.2 Isolation of protein from environmental samples
For the most part, the isolation of proteins from environmental samples is the same as it is
from an isolate or a tissue sample. Before this, however, certain types of samples need special
attention. For example, preterm infants often have a higher than usual load of human protein in
the fecal samples. In this case, to get a better representation of microbial proteins, the samples
can be size filtered to enrich the bacterial cells at the expense of the larger Eukaryotic cells
(Xiong et al. 2015). In soil, specific procedures need to be followed for the removal of humic
acid (Qian and Hettich 2017). After these steps, protein isolation can proceed as usual. These
kinds of steps are not needed for adult fecal samples. There are four main steps to prepare
samples for metaproteomics analysis: cellular lysis, isolation of protein, digestion, and cleanup.
This process is similar to the extraction of DNA except that for DNA, many of these steps have
been made routine by commercial kits. For metaproteomics, it is more typical for researchers to
use their own in-house protocol.
For lysis, samples are usually treated initially with chemical disruption using the detergent
sodium dodecyl sulfate (SDS) in tris-HCl lysis buffer at pH 8.0. SDS has the additional benefit
of denaturing the proteins and moving the fecal samples into solution. Next, samples are treated
with physical disruption either in the form of bead beating or sonication. Sonication has been
reported to achieve more efficient lysis; however, bead beating lyses cells sufficiently well, is
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compatible with DNA extraction, and can enable multiplexed processing of more samples at the
same time (Zhang et al. 2018). Finally, samples are heated to complete extraction and
denaturation by boiling for a specified period. These three steps should lyse cells sufficiently to
proceed to protein isolation; however, before that, the solution is typically treated with
dithiothreitol (DTT) to break disulfide bonds between cysteine residues. Iodoacetamide (IAA) is
then used to modify the cysteine residues so that the bond cannot be reformed.
After these steps, protein is isolated by precipitating it out of solution. This can be done by
adding trichloroacetic acid (TCA) or a solution made of chloroform, methanol, and water.
Removing the supernatant isolates the protein, which can be reconstituted in a proteolysis buffer,
such as an ammonium bicarbonate solution with sodium deoxycholate (SDC) as the denaturant.
Once reconstituted, protein concentration can be measured by bicinchoninic acid (BCA) protein
assay or a NanoDrop instrument set an UV absorbance of 205 nm or 280 nm. This concentration
is then used for determining the trypsin concentration needed for digestion into peptides. Trypsin
is the most common protease used for protein digestion in proteomics because it consistently
cleaves proteins at the lysine and arginine residues, narrowing the set of possible peptides. Once
the peptides have been digested, the samples are cleaned up and desalted. Size filtration removes
under-digested protein. SDC is removed using acid and ethyl acetate solution, which precipitates
the detergent allowing the rest of the solution to be extracted. Typically, at this step, formic acid
is added to protonate the peptides. The final peptide solution is quantified so that a consistent
amount of peptides can be added to the liquid chromatography system coupled to the mass
spectrometer.

2.3 Detection of proteins by mass spectrometry in environmental samples
Mass spectrometers are made up of three basic components: a source that converts
molecules into ions and delivers them into the mass spectrometer, a mass analyzer which
separates ions by mass-charge-ratio (m/z), and a detector which records the m/z of the ions along
with their relative abundance (intensity). Using these components, a mass spectrometer measures
the m/z and intensity of ions and plots these values on a histogram (mass spectrum) with m/z
along the x-axis and intensity (relative or absolute) along the y-axis. A simple m/z is not
sufficient information with which to distinguish peptide sequences. Thus, peptides are usually
further interrogated with an extension of this concept called tandem mass spectrometry
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(MS/MS). In MS/MS, ions are isolated in a mass analyzer by their initial m/z (MS1) and then
fragmented, producing a second mass spectrum of the fragmented ions (MS2).
Low-energy collision induced dissociation (CID) is an ion fragmentation method that can
be conducted in a linear-ion-trap (LTQ) mass analyzer. CID reliably fragments peptides at the
carbon to nitrogen bonds yielding fragmented ions traditionally termed b and y ions (Roepstorff
and Fohlman 1984, Hunt et al. 1986). These ions yield a mass spectrum that can be used to
partially sequence the isolated peptide (Figure 2.2). Other fragmentation methods yield different
sets of ions; however, CID is the most used for proteomics (Kim and Pandey 2012). Fragment
ions are numbered sequentially from smallest to largest with the b fragment ions numbered from
the N to the C-terminus, while the y ions are numbered from C to the N-terminus of a peptide
sequence. These ions are numbered from smallest to largest, and amino acids can be predicted by
subtracting a b or y ions by the preceding b or y ion, respectively (Figure 2.2) (Hunt et al. 1986).

Figure 2.2: Fragmentation by CID yields b and y ions, which can be used to sequence a peptide. (A) Locations at
which b or y ions can be fragmented and their numbering scheme from the N to C terminus. (B) An example MS2
scan where amino acids are inferred based on the difference in mass between y or b ions respectively.
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2.3.1 Instrument considerations for detection of proteins using mass spectrometry
Due to limitations in instrumentation and informatics, not all ions can be isolated,
fragmented, and detected at once. As such, a scheme for selecting ions for fragmentation across
time is necessary. For most proteomics measurements, ions are selected for fragmentation in a
data dependent manner, called data dependent acquisition (DDA) (Courchesne et al. 1998). First,
a full MS1 scan is recorded, and then ions are selected for fragmentation scans in order of
abundance from highest to lowest intensity. Typically, between 5-20 ions are sequentially
selected for fragmentation between MS1 measurements. Ions selected for fragmentation are
added to an exclusion list for a defined period so that the same abundant ions are not
continuously selected for fragmentation (Wang and Li 2008). An alternative method called data
independent acquisition exists (DIA) (Chapman et al. 2014). DIA fragments all the ions within a
given m/z window, providing the opportunity for more extensive fragmentation of ions;
however, the bioinformatics has not caught up to dealing with the heterogeneity of DIA derived
MS2 spectra in environmental samples (Saito et al. 2019).
The number of high-quality spectra generated by DDA can be increased by improvements
in the speed, fragmentation efficiency, mass resolution, and mass accuracy of the instrument
(Olsen et al. 2007, Mann and Kelleher 2008). Speed allows for more ions to be measured in a
narrower time frame. Fragmentation efficiency allows for better fragmentation of precursor ions
leading to a richer MS2 spectrum and allowing for better sequencing of the peptide by b and y
ions. Mass resolution determines the narrowness of peaks, calculated as the full-width-at-halfmaximum. The resolution allows ions of similar m/z to be better distinguished, allowing for
improved calculation of charge, better isolation of ions, and more accurate quantification. Mass
accuracy determines how close the measured m/z is to the real m/z, typically calculated in partsper-million (ppm). Mass accuracy narrows the window of possible peptides that can match to a
spectrum making it easier to infer a peptide sequence from the spectrum. Improvements in speed
typically come at the cost of resolution and accuracy.
To address these performance issues, hybrid instruments have been developed over the last
two decades to utilize the strengths of different mass analyzers. One of the first of these
instruments to revolutionize the field of proteomics was the LTQ-Orbitrap (Makarov et al. 2006).
At its most basic, this instrument contains a linear ion trap mass analyzer for the rapid isolation
and fragmentation of ions and an orbitrap mass analyzer for high accuracy and high-resolution
16

measurement of ions. This instrument can be run in a high-high mode where both precursor ions
and fragment ions are measured in the orbitrap while the ions are fragmented in the ion trap, but
this comes at the cost of speed. Alternatively, there is a high-low mode where the precursor is
measured in the orbitrap. However, the fragment ions are fragmented and measured more
quickly at lower resolution and accuracy in the ion trap. The high-low mode allows for the best
tradeoff between resolution, accuracy, and speed for maximizing the number of detected
peptides. This instrument was used in chapters 3 and 4 of this dissertation.
An improvement on this model is the Q-Exactive line of instruments (Michalski et al.
2011). This line of instruments replaces the linear ion trap with a quadrupole and uses an HCD
cell for fragmentation. In this instrument, the quadrupole isolates ions by m/z, while the HCD
cell fragments the ions in succession. Ions are then measured simultaneously in the orbitrap. This
allows for high-high measurements at a faster speed than the high-low measurements of the
LTQ-orbitrap. The HCD also fragments ions more efficiently than the CID implemented in the
LTQ, allowing for better peptide sequencing in the MS2 (Olsen et al. 2007). This process leads
to faster measurements in general, but also a higher proportion of high-quality measurements
both of which lead to fewer measurements needed in total and shorter overall measurement times
for the same number of peptides. This instrument was used in Chapter 5 of this dissertation.
Further development into hybrid instruments has led to tribrid lines of instruments, which
add a linear ion trap to the instrument. The additional mass analyzer adds more options for
fragmentation, allowing for MS3 and beyond tandem measurements. This type of fragmentation
is particularly important for quantification by isobaric labeling (Ting et al. 2011). As all
quantification in this dissertation was label-free, this line of instruments was not needed for the
dissertation.
For DDA to work, the mass spectrum needs a continuous source of ions. Soft ionization
sources, which allow for the ionization of intact peptides without fragmentation, were developed
in the 1980s. Matrix assisted laser desorption/ionization (MALDI) ionizes peptides by using
laser energy to convert peptides into ions from a matrix (Karas et al. 1985). The main advantage
of this approach is that it can ionize large molecules. Its disadvantage is that it is not easy to
maintain a constant flow of ions. The original metaproteomics experiment used MALDI to ionize
peptides located on electrophoresis gel spots using a quadrupole time-of-flight mass
spectrometer and was able to detect several hundred peptides (Wilmes and Bond 2004). An
17

alternative method of ionization, called electrospray, was created around the same time as
MALDI (Whitehouse et al. 1985). In this method, protonated peptides in solution flow through
an emitter with a high voltage applied to it. When the ions reach the tip of the emitter, they
aerosolize spraying into a heated capillary for desolvation, after which ions are guided into a
mass analyzer using electrostatic fields. The advantage of this approach is that it allows for the
continuous flow of ions into the mass spectrometer and can be coupled directly to a liquid
chromatography system for the online separation of peptides (Washburn et al. 2001).
An unseparated mixture of peptides will simply deliver peptides continuously at the same
time to the mass spectrometer, leading to the detection of only the most abundant peptides. To
increase peptide measurement depth, peptides need to be delivered to the mass spectrometer
separated over time (Peng and Gygi 2001). The most popular way of doing this is by reversephase liquid chromatography. In reverse-phase, the emitter/analytical column is packed with a
stationary phase made up of C18 hydrophobic beads that capture peptides as they flow through
the column. Then a solution gradient (mobile phase) from low hydrophobicity (typically water)
to high hydrophobicity (typically acetonitrile) is applied to the column. As the solution increases
in hydrophobicity, peptides are released from the stationary phase in order of their
hydrophobicity. The more gradual the gradient, the more time the measurement takes, the better
the separation between peptides, and the more peptides can be detected. This separation is
limited by the concentration of peptides delivered to the column, as too much separation relative
to the concentration of peptides can lead to a decrease in signal. One solution for this is to add an
orthogonal chromatography step before reverse-phase, called 2D liquid chromatography
(Washburn et al. 2001, Hinzke et al. 2019). In this dissertation, the additional chromatography
step had a strong cation exchange stationary phase. Peptides attach to the stationary phase by
charge and are released by increasing concentrations of salt, such as ammonium acetate. Peptides
are then released on to the analytical reverse-phase column stepwise using an increasing
concentration of salt. The first metaproteomics study to measure over 1,000 proteins in a human
gut microbiome was conducted using this 2D-LC-MS/MS method (Verberkmoes et al. 2008).
2.3.2 Algorithms for confident detection of peptides by tandem mass spectra
Unfortunately, CID does not yield a complete spectrum, thus making it difficult to predict
the full sequence of a peptide-based on this information alone. Two main algorithms have been
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developed to infer peptide sequences based on their CID fragmentation pattern. In the sequence
tag approach, a series of sequential fragment ions can be used to create a partial sequence tag
(Mann and Wilm 1994). This tag can be used in conjunction with the m/z of the precursor ion to
predict possibilities for the remaining amino acids, and then a sequence database can be used to
identify possible matching sequences. The alternative method, called database searching,
predicts a series of theoretical peptide spectra based on a database made up of protein sequences
likely to be in the sample (Eng et al. 1994). Then real spectra are matched to these theoretical
spectra, and the peptide spectral matches (PSMs) are scored based on the closeness of the match.
Modified peptides can also be detected by database searching (Yates et al. 1995). To detect
modifications, mass shifts specific to modifications of amino acids can be added to the
theoretical spectra list. Two of the most common modifications included in a database search are
oxidation of methionine and carbamidomethylation of cysteine. Carbamidomethylation of
cysteine is due to the addition of IAA during sample preparation. Database searching was
initially implemented in a software package called Sequest, but since then, a variety of
algorithms have been developed which follow the same principle with different scoring methods
(Tabb 2015). For a peptide to be detected by the database search method, it must be present in
the protein database; however, the sequence tag approach can provide at least a partial sequence
forming the basis for de novo peptide sequencing. The database searching approach maintains
more traction in the proteomics community due to its ability to reliably detect more peptides with
high confidence.
To ensure that only PSMs with highly confident scores are used to infer proteins, a PSM
false discovery rate (FDR) can be calculated, FDR = FP/(TP+FP)
where TP represents true positives and FP represents false positives (Elias and Gygi 2010). False
positives can be predicted by engaging in a target-decoy competition by creating a decoy protein
database of similar size and structure to the target protein database (Elias and Gygi 2007). The
decoy database, often generated by “reversing” all of the normal sequences, is then included in
the database search with the target database. Based on the results, a score threshold that yields
the desired FDR can be used for the identification of peptides. The accuracy of FDR prediction
can be improved using a semi-supervised machine learning approaches as implemented in
Percolator (Käll et al. 2007). The advantage of the semi-supervised approach is that multiple
scoring schemes can be implemented together in a test set to produce a false discovery rate
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prediction, which becomes more accurate the more PSMs are included in the analysis. False
discovery rates are often set at 1% for high confidence and 5% for medium confidence.
High or medium confidence peptides can be used to infer identified proteins. One way to
do this is to use the two peptide rule to provide confidence, and the unique peptide rule to
distinguish proteins that share peptides (Erickson et al. 2012); however, innovations in protein
false discovery rate calculation allow for the combination of multiple factors including
uniqueness, number of peptides, and PSM score in the inference of identified proteins (Figure
2.3). In this case, proteins with only a single peptide detected, but with high confidence, can be
inferred at a reasonable false discovery rate (Gupta and Pevzner 2009, Serang et al. 2010). In the
case of Eukaryotic organisms, the unique peptide rule is sometimes not reasonable, as multiple
proteoforms make it difficult to resolve certain proteins with a unique peptide. In this case,
proteins that share peptides are grouped into a protein group, called a master protein, and
inferred together. In metaproteomes, however, the need to distinguish detected proteins by
organism outweighs the benefit of protein groups, and as such, the unique peptide rule is critical.
2.3.3 Creation of a protein database for database searching
The most crucial consideration for detecting proteins in an environmental sample is the
protein database. This is most clearly exemplified by a study that showed that using different
protein databases on the same measurement could have a profound impact on the taxonomic
composition of the sample inferred from the metaproteome (Timmins-Schiffman et al. 2017).
This study implied that using a generic protein database for database searching has the potential
for generating erroneous results. Database searching cannot detect peptides that are not in the
database, leading to missed PSMs if the protein database is incomplete. FDR calculation relies

Figure 2.3: Workflow for the inference of proteins from peptides based on database searching. Proteins can then be
used to infer metabolic function based on their annotations.
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on a significant separation in score between true positives and false positives. The less
representative the database is of the sample, the lower the separation in score between true and
false positives. In a typical proteomics study, this is not that great of a problem. If the genome of
the organism has been sequenced, a mostly complete protein database can be created for the
proteomic analysis. Even if the organism is not sequenced, the genomes of closely related
organisms have been used to some success (Waridel et al. 2007). In the case of environmental
samples, however, it is impossible to know the genetic composition of the sample in advance
because prior sampling of the same community type does not imply the same gene content.
A solution to this problem that is gaining substantial traction in the metaproteomics
community is the use of system-specific gene catalogs. Due to the HMP and Metahit projects,
human microbiomes have been heavily sequenced, and extensive repositories of their gene
content have been created (Qin et al. 2010, The Human Microbiome Project 2012). Several
groups have suggested using these catalogs for an initial database search, and to use the results
from that search to create sample-specific databases (Jagtap et al. 2013, Muth et al. 2015, Zhang
et al. 2016). Then raw data of each sample can be re-searched against its specific protein
database for FDR calculation. This approach, however, is not broadly applicable. For most types
of microbial communities, many of the organisms remain un-sequenced and, as such, are not
well represented in public repositories.
To illustrate that many microbiome communities remain underrepresented in sequence
repositories, a simple experiment was conducted. Protein databases derived from a human
preterm infant metagenome project, a mouse metagenome project, and a switchgrass microbiome
project were each used to see how represented they were in major public repositories of
sequencing information. The human and mouse metagenomes are from Chapter 4 and Chapter 5,
respectively. Payal Chirania from the Hettich lab kindly provided the switchgrass metagenome.
A blast search was conducted between the protein sequences in these three databases and the
UniParc database, which is representative of all known protein sequences (The UniProt 2018).
The percent sequence identity for the top hit of each protein was recorded (Figure 2.4). For the
human metagenome, the median sequence matched with 100% identity. This match suggests that
using a catalog is a feasible approach for human gut microbiomes; however, for the mouse and
switchgrass metagenomes, the median sequence matched with less than 80% identity to the
UniParc database. This result suggests that the mouse and switchgrass metagenomes were not
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well represented at even the genus level in the primary sequence repositories. Based on this
information, the catalog approach appears to not be appropriate for samples taken from
environments other than the human body, including the mouse, which has a reasonably wellstudied gut microbiome. The mouse result was surprising, given that the mouse
gut microbiome has a published gene catalog (Xiao et al. 2015). The certainty of using a gene
catalog on the human gut microbiome is also not so clear. There were still protein sequences in
the human protein database that matched to UniParc proteins with less than 20% identity, and a
recent manuscript found thousands of new species uncovered from non-traditionally sequenced
populations (Pasolli et al. 2019). Therefore, even analyzing a human metaproteome without prior
sequencing is risky since there is a chance that the community has not already been sequenced.
To ensure accurate protein sequence representation in the protein database, parallel metagenomic
sequencing with metaproteomics is recommended. There is some resistance to this in the
metaproteomics community, as the assembly of metagenomes is expensive and requires
additional expertise (Zhang et al. 2016); however, this is a weak argument as over the last decade
academic and commercial sequencing centers have become ubiquitous, and all the tools needed

Figure 2.4: Percent amino acid identity between protein databases and their top hits in UniParc. Protein databases
where derived from metagenomes that where part of a mouse, switchgrass, and human preterm infant study.
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to assemble raw sequence data into discrete metagenome assembled genomes (MAGs) have been
made freely available and easy to use (Figure 2.5).
Metagenome assembly typically proceeds as follows. Raw sequencing reads are quality
checked and trimmed if necessary. In the case of fecal samples, host DNA can be removed using
an aligner; however, in this dissertation, it was found that host sequences are easily identifiable,
so this may not be necessary. Cleaned short-reads can then be extended into contigs or scaffolds
using metagenome specific assemblers (Peng et al. 2012, Li et al. 2015). At this point, bacterial
gene predictors, like MetaGeneMark or Prodigal, can predict genes in contigs with greater than
1,000 sequences (Hyatt et al. 2010, Zhu et al. 2010). Although some progress has been made
recently, Eukaryotic gene calling remains difficult (West et al. 2018). These gene calls can be
used to make a basic metagenome derived protein database as was done in Chapter 3; however,
clustering the contigs into genomes can improve the metagenomes. Using a sequence aligner,
reads from multiple samples can be mapped back to contigs to estimate differential coverage (Li
and Durbin 2009). Then contigs can be clustered into genomes using differential coverage and
tetranucleotide frequency (Kang et al. 2019). Quality of genomes can be assessed for
completeness and redundancy (contamination) using single-copy genes (Parks et al. 2015), and
redundant genomes can be removed by average nucleotide identity (ANI) retaining the highest
quality genome (Olm et al. 2017). Using these steps, it is relatively routine to extract a large
number of medium quality genomes, defined as greater than 50% complete and less than 10%
contaminated (Bowers et al. 2017). Genomes that do not quite meet this threshold can be further
refined by individually clustering their contigs by tetranucleotide frequency and genome
coverage and removing outliers (Figure 2.6) (Eren et al. 2015). A pipeline along these lines was
developed for Chapter 5, while the protein database for Chapter 4 was derived from an older,
more manually derived set of metagenome assembled genomes (Brown et al. 2018).
Not all metagenomes are created equal. A shallow metagenome can lead to an incomplete
gene list leading to false-negative protein identifications. To mitigate the creation of a shallow

Figure 2.5: Typical workflow for the construction of protein databases from genome resolved metagenomics
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Figure 2.6: Example of refining a metagenome assembeled genome in Anvi’o. Contigs are clusered by
tetranucleotide frequency and outlier contigs are removed. This genome was adjusted from a completion score
97.5% and a contamination score of 18.38% to a completion score of 96.79% and a contamination of 0%.

metagenome, samples can be preemptively sequenced using 16S rRNA sequencing to predict the
size of the community to be profiled. This information can be used to predict how much
sequencing is needed to achieve a specific coverage for all the genomes in the community, as
was done in Chapter 5. Another solution is to combine metagenomes assembled from multiple
samples from the same experiment. To test the effect of combining metagenomes, preliminary
searches were conducted on the data from Chapter 4. Each sample from a single individual was
searched against its sample-specific metagenome and a few different formulations combining all
the metagenomes from that individual. It was found that combining metagenomes led to a
significant increase in the number of peptides detected (Figure 2.7). This implies that it is not so
much database size, but the appropriateness of the database that affects the number of proteins
detected confirming the need for parallel sequencing for metaproteomic analysis. Combining
metagenomes has the added benefit of comparing metaproteomes from different samples on the
same footing since all the metaproteomes had equal opportunity to detect the same peptides.
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Figure 2.7: Number of distinct peptides detected using different protein database formulations. All the
metaproteomes from a single preterm infant were searched using different formulations of the infants metagenome:
just the sample specifc metagenome, all the metagenomes from the infant, all the metagenomes that had an
associated proteome, and all the metagenomes clustered at 100% identity. Sample specific had a significnatly
lower number of peptides detected (P<0.01).

A problem with combining metagenomes is that gene callers provide sequential identifiers
for genes as they are predicted. The addition of sequential identifies means that the same protein
sequence across two metagenomes will have a different identifier. Clustering across all
metagenomes involved in a single metaproteomics study can resolve this redundancy by creating
a non-redundant list of protein sequence identifiers (Fu et al. 2012, Xiong et al. 2015). Removing
redundancy is also necessary so that non-redundant proteins can be inferred by peptides unique
to the sequence, not the identifier. There is some debate about the ideal amino acid percent
identity for this clustering approach. In Chapter 3, the clustering cut-off was set at 90% identity
because this was the point at which the number of additional unique peptides per sample
plateaued. In Chapter 4, the cut-off was set at 100% identity to ensure subspecies level
discrimination between proteins. In contrast, for Chapter 5, this cut-off was adjusted to 98%
identity after it was found that 97% of protein sequences could still be resolved down to the
species level.
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2.4 Assigning function and taxonomy of origin to proteins detected in
environmental samples
Detected proteins do not independently provide any biological information. All
information about the taxonomy and function of detected proteins is inferred from the protein
sequences found in the protein database. After the detection of proteins in an environmental
sample, the next step is to infer the function and taxonomy of origin of said proteins and to use
that information to infer functional differences between conditions.
2.4.1 Assignment of taxonomy based on database
Assigning taxonomy to proteins detected in a metaproteome is not simple. A suggestion
that is gaining substantial prominence in the metaproteomics community is to match the detected
peptides to a sequence repository and report the lowest taxonomic rank that the peptide is unique
to, as implemented in UniPept and METATRYP (Mesuere et al. 2012, Saito et al. 2015).
UniPept uses the UniProt database as the background for this analysis, while METATRYP uses a
custom domain-specific database. The problem with this approach is that it assumes that a
peptide that is unique to a database is also unique to the entire domain of life. Preliminary
analysis in Chapter 5 of this dissertation showed at least one instance of a peptide being traced to
a specific strain, where that strain was not in the metagenomes, and the actual protein that was
detected by that peptide was from a species whose genera was not present in UniProt. The
organism predicted by UniPept and the actual organism of origin ended up being from the same
family; however, this simple observation shows how UniPept like approaches are capable of
erroneous results. An alternative solution is to use the full sequence to identify the taxa of origin.
Several metagenomics tools can do this either by exact match or by sequence similarity searches
(Huson et al. 2007, Kim et al. 2016, Menzel et al. 2016). Even the Kyoto Encyclopedia of Genes
and Genomes (KEGG) internal annotator, Ghost KOALA, offers genus and phylum level
assignments based on the sequences that match the protein sequence of interest (Kanehisa et al.
2016). These approaches, however, fall into the same trap as UniPept by assuming that a
reference database is representative of the environmental sample in question. Also, these
approaches assume that simply because two protein sequences have highly similar sequences that
the overall genomes these sequences belong to will have the same evolutionary history; however,
it is well known that the phylogenetic history of a specific gene often does not align with
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phylogenetic history of the species as a whole (Maddison 1997, Dewhirst et al. 2005, Szöllősi et
al. 2014, Zhu et al. 2019).
All the genes in a metagenome assembled genome rarely match the same species when
compared to a sequence repository. This can be shown simply by blast searching all the proteins
found on any random scaffold in a metagenome. As illustrated in the table below, the protein
sequences will not necessarily match the same species (Table 2.1). A solution to this problem is
to use metagenome assembled genomes to assign taxonomy to protein sequences in microbial
communities. Using this method, one can assign taxonomy based on the average taxonomical
assignment of all the genes in a genome as proposed by the Banfield group, or one can assign
taxonomy by placing the whole genome in a phylogenetic tree made up of all the genomes found
in NCBI, as proposed by the Genome Taxonomy Database (Brown et al. 2018, Parks et al. 2018,
Chaumeil et al. 2019). These approaches also have the added advantage of being able to assign a
protein to a species group even if its genome of origin is not found in any major sequence

Table 2.1: A series of protein identifiers taken from a randomly selected scaffold from a human preterm infant
metagenome. Each protein was searched using Ghost KOALA and blast.
Gene
b019-d013_scaffold_31_16
b019-d013_scaffold_31_17
b019-d013_scaffold_31_18
b019-d013_scaffold_31_19
b019-d013_scaffold_31_20
b019-d013_scaffold_31_21
b019-d013_scaffold_31_22
b019-d013_scaffold_31_23
b019-d013_scaffold_31_24
b019-d013_scaffold_31_25
b019-d013_scaffold_31_26
b019-d013_scaffold_31_27
b019-d013_scaffold_31_28
b019-d013_scaffold_31_29
b019-d013_scaffold_31_30
b019-d013_scaffold_31_31
b019-d013_scaffold_31_32
b019-d013_scaffold_31_33
b019-d013_scaffold_31_34

Ghost KOALA
Genus
Lelliottia
Enterobacter
Enterobacter
Enterobacter
Enterobacter
Enterobacter
Enterobacter
Enterobacter
Enterobacter
Lelliottia
Leclercia
Leclercia
Enterobacter
Leclercia
Kluyvera
Leclercia
Enterobacter
Enterobacter
Leclercia

Whole Genome Taxonomy
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
Enterobacter cloacae 7
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NCBI Blast
Enterobacter hormaechei
Enterobacter cloacae
Enterobacter hormaechei
Enterobacter cloacae
Enterobacter cloacae
Enterobacter hormaechei
Enterobacter cloacae
Enterobacter cloacae
Enterobacter cloacae
Enterobacter hormaechei
Enterobacter hormaechei
Enterobacter hormaechei
Enterobacter hormaechei
Enterobacter hormaechei
Enterobacter cloacae
Enterobacter hormaechei
Enterobacter cloacae
Enterobacter cloacae
Enterobacter hormaechei

repositories. It is the opinion of the author of this dissertation that this should be the norm not
only for metaproteomics but for microbiome analysis in general.
2.4.2 Assignment of function to detected proteins
The assignment of function to a protein sequence requires two basic elements: a language
by which to define a biological function, also known as an ontology, and a method for
transferring information between proteins that have an experimentally confirmed function and
proteins that do not. There are many different ontologies, but the two most well-known are the
genome ontology (GO) (Gene Ontology 2015), and the enzyme commission (E.C) (Bairoch
2000). The advantage of E.C. is that it offers a set of unique identifiers for all known enzymatic
reactions with experimental evidence, while its main disadvantage is that it only
provides functional information for proteins that are enzymes. GO provides a common language
for all biological functions performed by genes; however, it is organized as a hierarchy that
combines broad and specific biological functions, and any function a gene is associated with is
added to that gene, whether it performs that function explicitly or if it is just associated. This
ambiguity makes it difficult to infer the specific function of a given gene. The primary purpose
of GO is to identify enriched functions based on a set of genes, typically called gene set
enrichment analysis (Mi et al. 2019).
The most common method of functional transfer is homology, defined as proteins that
have a common ancestor. Within homology, orthologs are homologs found in different
organisms, while paralogs are homologs found within the same organism, possibly due to a gene
duplication event (Li et al. 2003). It is typically assumed that orthologs are better choices for
functional transfer even though paralogs often have more similar sequences. There are several
publicly available databases of orthologous protein groups that provide functional annotations
based on experimental evidence from member proteins, e.g., KEGG, eggNOG, COG (Tatusov et
al. 2000, Huerta-Cepas et al. 2016, Kanehisa et al. 2016). Orthologous proteins are grouped
using sequence similarity. The most basic approach is an “all versus all” blast followed by
Markov clustering (Enright et al. 2002). This approach has two advantages. Blast includes the
probability of amino acids switching between each other in its scoring method, offering a more
evolutionarily relevant score, and Markov clustering performs a random walk through the
network of similar proteins cutting any spurious links. This clustering is meant to account for
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promiscuous domains. This approach is the fundamental basis for eggNOG and COG, while
KEGG orthology uses a more loosely defined threshold based on the functionality of proteins.
KEGG uses E.C. numbers as the basis for a fairly extensive library of enzymatic
reactions assigned to its orthologs, while eggNOG taps into the KEGG orthology for enzymatic
information and GO for more general functional information. Since this Ph.D. process started in
2014, functional transfer with one of these databases has become relatively routine, as most of
them now offer tools for annotating proteins with their orthologous groupings, after which
associated functions such as E.C. or GO can be added to the queried protein sequences (Figure
2.3). Today, it is possible to annotate over a million sequences in under 24 hours.
2.4.3 Analyzing function in environmental samples:
After functional ontologies have been assigned to proteins, the next step is to infer
functional differences between conditions. In a typical proteomics experiment, this is done by
identifying proteins that are significantly different in abundance between conditions and then
using the proteins that are up or down in that condition as gene sets for enrichment analysis
(Poudel et al. 2019). In the case of a single organism, differences in protein abundance reflect
changes in gene expression, and it is a fair assumption that changes in protein abundance reflect
changes in function. In microbiomes, however, protein function is highly redundant between
organisms, as will be shown in Chapter 3, and differences in protein abundance can be more
reflective of changes in community composition, as will be shown in Chapter 5. In many cases,
the functions enriched for proteins that are up or down between conditions are the same. This
similarity invalidates the utility of gene set enrichment analysis. Since the main strength of the
genome ontology is gene set enrichment, it is likely not the best approach for looking at changes
in function in microbial communities. An alternative approach is to use protein abundance to
quantitate specific functions such as those associated with KEGG orthologs and do a quantitative
differential function analysis.
There are two main label-free approaches to quantitate proteins. One is to count the
number of spectra assigned to a protein (McIlwain et al. 2012), and the other is to use the MS1
feature intensity of detected peptides to determine protein abundance (Argentini et al. 2016).
Typically, MS1 feature intensity is considered the more accurate approach; however, recent
evidence suggests that spectral counting may be at least as accurate as MS1 features in
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metaproteomes (Kleiner et al. 2017), and spectral counts are substantially easier to calculate.
Results from these quantifications can be summed into specific functional ontologies to create a
functional abundance, which can then be compared statistically. One issue with this approach is
that it is a fairly confusing metric since it is driven by the expression of the proteins within their
originating organism, the abundance of the originating organism, and how many proteins are
being detected with that function overall. An alternative quantification method could be to
simply count the number of proteins associated with a function. This metric simply tabulates the
number of proteins expressed above the limit of detection for a specific function and may be
more indicative of a bulk transition in gut microbiome function.

2.5 Conclusions
The main objective of a metaproteomics study is to use the suite of measured/identified
proteins to infer the functionality of an environmental sample and trace that function back to its
taxonomies of origin based on the annotation of protein sequences. This chapter has presented
many of the considerations needed to reach that point and suggested some methodologies which
were used in the following chapters. This dissertation focuses on describing metabolic function
in gut microbiomes. As such, the taxonomy of origin was not particularly emphasized in any of
the Chapters; however, phyla of origin could be traced for individual functions across all
chapters, and in Chapters 4 and 5, functions could be traced back to species or even subspecies
of origin.
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METAPROTEOMICS REVEALS PERSISTENT AND PHYLUMREDUNDANT METABOLIC FUNCTIONAL STABILITY IN ADULT

HUMAN GUT MICROBIOMES OF CROHN’S REMISSION PATIENTS
DESPITE TEMPORAL VARIATIONS IN MICROBIAL TAXA,
GENOMES, AND PROTEOMES
Text and figures were adapted from:
Blakeley-Ruiz, J.A., Erickson, A.R., Cantarel, B.L., Xiong, W., Adams, R., Jansson, J.K., Fraser,
C.M., Hettich, R.L. Metaproteomics reveals persistent and phylum-redundant metabolic
functional stability in adult human gut microbiomes of Crohn’s remission patients despite
temporal variations in microbial taxa, genomes, and proteomes. Microbiome 7, 18 (2019).
https://doi.org/10.1186/s40168-019-0631-8
J. Alfredo Blakeley-Ruiz contributions include data analysis, writing of original manuscript,
revision, and response to reviewers.

3.1 Introduction
The composition of the gut microbiota can vary quite substantially across time and
individuals. Many factors have been shown to impact this variation, including diet, geography,
age, genetic relatedness, and health status (Erickson et al. 2012, Yatsunenko et al. 2012, David et
al. 2013). Given the number of possible host factors influencing the gut microbiota, it becomes
difficult to tease apart what precisely separates the gut microbiota in healthy versus unhealthy
individuals. One potential approach to this complicated question is to focus on discrete
“metabolic modules” in a gut microbiome, rather than taxa membership or genomic inventory.
Many different bacteria share the ability to perform similar metabolic functions. Hence,
microbiomes with very different taxonomic and protein compositions could share a substantial
functional similarity, suggesting that functional redundancy in microbial membership may
provide an environmental health advantage (Moya and Ferrer 2016). Since proteins are critical
participants in the functional activity of life, the direct detection of microbiome-relevant proteins
via metaproteomics is ideally suited to help tease apart this problem, and to this end, several
studies have demonstrated the ability of LC-MS/MS to measure gut metaproteomes from fecal
material, providing a framework for potentially observing gut microbiome function via direct
protein detection (Verberkmoes et al. 2008, Erickson et al. 2012, Xiong et al. 2015, Zhang et al.
2018).
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A few studies have investigated the gut metaproteomes of preterm infants and healthy
adults across time and these studies have revealed variability in both the protein identities as well
as overall metabolic activities (Kolmeder et al. 2012, Kolmeder et al. 2016, Xiong et al. 2017).
Recently, the temporal dynamics of the gut microbiome composition was determined by 16S
rRNA gene sequencing in an inflammatory bowel disease cohort, that included subjects with
Crohn's disease (CD) having inflammation either in the ileum (ICD) or the colon (CCD), as well
as subjects with ulcerative colitis and healthy individuals (Halfvarson et al. 2017). All of the
subjects with IBD exhibited more volatility in microbiome composition over time compared to
healthy individuals, but the degree of dysbiosis from healthy was significantly higher for the ICD
patients that had undergone surgery. The question remaining is how this volatility influences
functions carried out by the gut microbiome.
To examine this issue, an integrated metagenomic/metaproteomic approach was designed
to investigate the longitudinal stability and variability in the gut metaproteomes of Crohn’s
diseased patients post resection-surgery. In contrast to previous studies, the focus of this work
seeks to go beyond taxa, gene, and protein profiling to investigate microbial metabolic activity at
a higher functional level to observe how persistent and redundant function is maintained across
varying microbial gut populations. Fecal samples were collected from several adult individuals
in remission (post resection surgery) over the course of one year (25 samples in total, and five
samples per individual). Metagenomic and metaproteomic data revealed persistent and phylumredundant metabolic functions despite a significant level of variability in taxa, genes, and
proteins.

3.2 Methods
3.2.1 Patient Cohort
This study focused on five human subjects (labeled as P58, P68, P33, P92, and P104),
each with a history of Crohn’s Disease and resection surgery, which were selected (as detailed
below) from a larger Swedish cohort that has been described previously (Halfvarson et al. 2017).
Five subjects were selected who had multiple fecal samples collected over one year.
Representatives of both sexes were included in the study (3 females and 2 males) and the
subjects were all adults (youngest, born 1967; oldest born 1944). All subjects had undergone
resection surgery prior to 2008 (Table 3.1).
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Community DNA preparation
Stool (fecal) samples were self-collected and shipped within one day to Dr. Jonas
Halfvarsson at the Orebro University Hospital in Orebro, Sweden, where they were immediately
frozen at -70 ͦ C upon arrival. The samples were stored frozen until use, and then small portions
were excised and thawed immediately prior to DNA extraction to avoid freeze-thaw damage.
DNA was extracted from 250 mg of each fecal sample in duplicate. For processing, samples
were thawed at 4°C and, in aliquots of 0.15 g per tube, resuspended in 1 ml of 1× phosphatebuffered saline. Cell lysis was initiated with two enzymatic incubations, first, using 5 µl of
lysozyme (10 mg ml−1; Amresco, Solon, OH), 13 µl of mutanolysin (11.7 U µl−1; SigmaAldrich), and 3 µl of lysostaphin (4.5 U µl−1; Sigma-Aldrich) for an incubation of 30 min at
37°C and, second, using 10 µl proteinase K (20 mg ml−1; Research Products International, Mt.
Prospect, IL), 50 µl 10% SDS, and 2 µl RNase (10 mg ml−1) for an incubation of 45 min at
56°C. After the enzyme treatments, cells were disrupted by bead beating in tubes with lysing
matrix B (0.1-mm silica spheres; MP Biomedicals, Solon, OH), at 6 m s−1 for 40 s at room
temperature in a FastPrep-24 (MP Biomedicals). The resulting crude lysate was processed using
the ZR fecal DNA miniprep kit (Zymo, Irvine, CA) according to the manufacturer’s
recommendations. The samples were eluted with 100 µl of ultrapure water into separate tubes.
DNA concentrations in the samples were measured using the Quant-iT PicoGreen doublestranded DNA (dsDNA) assay kit (Molecular Probes, Invitrogen, Carlsbad, CA) (Zhang et al.
2018).
3.2.2 Shotgun metagenomic sequencing and assembly
DNA isolation from stool samples yielded 3 – 5ug of purified metagenomic DNA from
each of the fifteen samples. All metagenomic samples were sequenced using the Illumina
platform. Illumina libraries were prepared with the DNA Prep Kit (Illumina, San Diego, CA)
following a variation of the manufacturer’s protocol. Following library construction, each sample
was subjected to cluster amplification (cBOT) and paired-end sequencing using an Illumina
HiSeq2000 according to manufacturer specifications. Raw sequence data were processed using a
combination of Illumina RTA/CASAVA software for base-calling and quality scoring and inhouse QC pipelines to filter and truncate low-quality reads. Sequences were assembled using
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Table 3.1: Description of Crohn’s disease patient cohort.
AB stands for antibiotics and MG stands for metagenome.

Patient
#
33
33
33
33
33
33
58
58
58
58
58
68
68
68
68
68
92
92
92
92
92
104
104
104
104
104
104

Sample
Name
A022
A64
A120
A177
B75
B190
A49
B93
A150
B11
B135
A52
A105
A158
B40
B152
A42
A91
A144
B6
B125
A30
A77
A131
A194
B99
B187

Day
0
82
175
259
361
441
0
73
171
263
352
0
91
175
274
357
0
88
177
282
367
0
84
173
259
362
427

AB MG

Birth
Extent of
Gender Smoker
Stricturing
Year
Disease

Yes
Yes

1944

F

Yes

Ileocolon

No

Yes 1949

F

No

Ileocolon

Yes

M

Ex

Ileocolon

Yes

F

Yes

Terminal
Ileum

Yes

M

No

Terminal
Ileum

Yes

Yes
Y
Yes

Y
Y
Y
Y

Yes
Yes
Yes 1952
Yes
Yes
Yes 1961
Yes
Yes
Yes

Y
Y

1967

Yes
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NEWBLER by subject after read reduction using khmer (Kumar and Blaxter 2010, Crusoe et al.
2015). Genes were predicted using MetaGeneMark (Zhu et al. 2010). Default parameters were
used for all assembly related software. Amino acid sequences of all the predicted genes were
then compiled into five individual specific protein databases (each one consisting of a single
concatenated, de-replicated metagenome of all three time-points per individual). The
metagenome sequence data can be retrieved using the following URL for the NCBI SRA data
deposit, under project ID 46321:
http://www.ncbi.nlm.nih.gov/sites/entrez?db=bioproject&cmd=Retrieve&dopt=Overview&list_u
ids=46321
3.2.3 Metaproteomics sample collection
Each fecal sample for metaproteome measurements (~130 mg for each sample) was
solubilized in 1 mL SDS lysis buffer (4% w/v SDS, 100 mM Tris·HCl (pH 8.0), 10 mM
dithiothreitol (DTT)), sonically disrupted (40% amplitude, 10s pulse with 10s rest, 2 min total
pulse time), incubated at 95°C for 5 min, and centrifuged at 21,000 x g. An aliquot of each crude
protein extract was quantified using a bicinchoninic acid (BCA)-based protein assay kit (Pierce),
and yielded about 4 mg/mL protein for each sample. The crude protein extract was precipitated
by trichloroacetic acid (TCA), pelleted by centrifugation, and washed with ice-cold acetone to
remove lipids and excess SDS, as described previously (Erickson et al. 2012). The protein
precipitates were resolubilized via sonication in 500 uL of 8M urea in 100 mM Tris·HCl (pH
8.0) and reduced by incubation with DTT at a final concentration of 10 mM for 1 hr at room
temperature. Samples were normalized for total protein at this step by using 1 mg of crude
protein for each sample, which was then diluted further with 100mM Tris·HCl and 10mM CaCl2
(pH 8.0) to a final urea concentration below 4M. Proteolytic digestions were initiated with
sequencing grade trypsin (1/100, w/w; Promega) and incubated overnight at room temperature. A
second aliquot of trypsin was added (1/100) after the reactions were diluted with 100mM
Tris·HCl (pH 8.0) to a final urea concentration below 2M. Following digestion, the peptides
were acidified (protonated) in 200mM NaCl and 0.1% formic acid, filtered with a 10kDa
molecular weight cutoff spin column (Sartorius) to remove under digested proteins. Final
peptide solutions were then was quantified using bicinchoninic acid (BCA)-based protein assay
kit (Pierce) to enable uniform sample injection onto the LC column.
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3.2.4 LC-MS/MS
Peptide mixtures were analyzed in technical replicate measurements via two-dimensional
liquid chromatography tandem mass spectrometry (LC/LC-MS/MS) on an LTQ-Orbitrap-Elite
mass spectrometer (ThermoFisher Scientific). Peptides (100 ɥg per sample) were loaded and
separated on-line using a bi-phasic 2D (strong-cation exchange (SCX) and C18 reverse phase
(RP))-LC column. Each peptide sample was first washed off-line to remove residual urea and
NaCl, and was then placed in-line and analyzed via 22-h 2D-LC-MS/MS. All samples were
analyzed by 11 salt pulses (5%, 7.5%, 10%, 12.5%, 15%, 17.5%, 20%, 25%, 35%, 50%, and
100% of 500 mM ammonium acetate) each followed by a 110 min gradient to 50% solvent B
(70% acetonitrile, 30% HPLC grade water, 0.1% formic acid) with the following profile: 0 to
10% solvent B in 10 min, 10 to 35% solvent B in 75 min, and 35 to 50% solvent B in 25 min.
Mass spectral data were acquired using Xcalibur in data-dependent acquisition mode for each
chromatographic separation. One precursor MS scan was acquired in the Orbitrap at 30K
resolution followed by ten data-dependent MS/MS scans (m/z 400-1700) at 35% normalized
collision energy with dynamic exclusion enabled at 1.
3.2.5 Informatics and quantification
Custom-built FASTA target-decoy databases were generated for each individual by
combining that individual’s specific protein database mentioned above with the human genome
and common contaminants. The MS raw data for each sample was searched against the
individual specific protein database using MyriMatch/IDPicker with a PSM FDR filter of less
than 2% (Tabb et al. 2007, Ma et al. 2009). MyriMatch automatically concatenates a reversed
database to the forward version prior to searching to enable proper false discovery rate (FDR)
calculation. Protein sequences were clustered into protein groups at ≥ 90% sequence identity
using USEARCH (v5.0) (Edgar 2010). A protein group was classified as identified if it had at
least one unique peptide and two distinct peptides, as resolved with in-house scripts. Protein
groups were assigned spectra using spectral balancing, as previously described (Abraham et al.
2012, Young Jacque et al. 2015, Xiong et al. 2017).
3.2.6 Data analysis
The protein databases were functionally annotated with Kyoto Encyclopedia of Genes
and Genomes (KEGG) orthologous groups, and phylum and genus level taxonomical
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assignments using Ghost KOALA (Kanehisa et al. 2016). Phylum level taxonomy and KEGG
orthologous groups were assigned to each protein group using the Ghost KOALA annotations of
the seed sequence for each protein group. The KEGG assignments to each identified protein
group were further used to infer and quantify human gut microbiome specific metabolic modules
using GOmixer (Darzi et al. 2015, Vieira-Silva et al. 2016). A metabolic module was inferred if
≥ 33.3% of the enzymatic steps in the module were covered within a single phylum. To examine
statistical variance of these samples, Spearman correlation coefficient was calculated by loading
a tab-delimited file containing identified protein groups and their abundance per technical
replicate into Perseus (v1.5.8.5.). The subsequent correlation matrix was rendered in a
hierarchically clustered heatmap (Figure 2) using the Euclidian distance metric in gplots
(Tyanova et al. 2016, Warnes et al. 2016, R Core Team 2017). Functional influence of each
phylum was calculated by taking the total number of KEGG orthologous groups identified with
protein evidence in each phylum by sample and dividing that by the total number of KEGG
orthologous groups found in the sample’s protein database.

3.3 Results
3.3.1 Sequence-guided sample selection and metagenome assembly
16S rRNA sequences were previously generated and published for 135 fecal samples
from a Swedish cohort of IBD patients and healthy subjects (Halfvarson et al. 2017). From this
same sample collection, five individuals with ileal Crohn's disease (ICD) were selected for
deeper analysis of microbial function by metagenomics and metaproteomics because these ICD
individuals showed the greatest microbiome volatility and were the most disparate compared to
healthy individuals (Halfvarson et al. 2017). Shotgun metagenomic sequence data were
generated from three fecal samples per each individual, corresponding to an initial time point and
at 2 subsequent 6-month intervals. Metaproteome measurements were conducted on the same
samples, plus an additional two intervening time-points for each individual; ensuring that the
protein data was adequately represented by metagenomes on either side of the sampling dates.
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3.3.2 Individual gut metaproteomes reveal substantial proteome variability
A total of 14,850 non-redundant protein groups were identified in this study from the 25
samples. Of these protein groups, 494 were human, and 14,356 were microbial. A total of 7322,900 microbial and 119-222 human protein groups were found in each sample (Figure 3.1A).
Although relatively few human protein groups were identified in total number, they were quite
abundant in most samples and comprised a substantial proportion of the assigned spectra. (Figure
3.1 B). The measurement correlation for all technical replicates had an R2 greater than 0.9 and a
slope within 0.1 of 1, indicating high technical reproducibility (Figure 3.2).

Figure 3.1: Number of proteins detected in Chron’s subjects. Box plots of (A) the number of microbial (blue),
human (orange), and total (grey) protein groups per sample and (B) the number of spectral counts assigned to
each of those groups per sample.
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Figure 3.2: Technical reproducibility of Chron’s samples from several perspectives. (A) Distribution of
Spearman Correlation Index of raw spectra, Pearson Correlation Index of Log2 transformed spectra, and
Pearson Correlation Index of raw spectra for each sample. (B) Percentage of the total protein groups
identified in each sample that were found in both technical duplicates. (C) Linear fit of raw spectra
identified in both technical replicates of sample P92_d177. Sample P92_d177 had the highest technical
reproducibility per Spearman correlation index. (D) Linear fit of raw spectra identified in both technical
replicates of P104_d259. P104_d259 had the lowest spearman correlation.
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As evident by the number of protein groups identified in each sample, qualitative
variation between samples was high. Relatively few identical microbial protein groups were
observed in all samples. Additionally, only 168 microbial protein groups were observed at least
once in every individual. Even within a single individual, qualitative variation was high. In
individual P104, only 7% of the microbial protein groups identified in that individual were
observed across all time points (Figure 3.3). Individuals P33, P104, and P92 had the most varied
metaproteomes across time, whereas P58 and P68 had more stable metaproteomes. However,
even though individual P58 had the most qualitatively stable metaproteome, less than 36% of its
microbial protein groups were found across all time points (Figure 3.3).
With this much variation, it was deemed that Spearman correlation coefficients were best
suited to quantify the similarity or dissimilarity of the metaproteomes between measurements
(Figure 3.4). Hierarchical clustering of the correlation between measurements revealed a
personalized metaproteome. Spearman correlation coefficients not only clustered strongly by
technical replicated measurements from the same sample, but also between measurements of the
different time points of the same individual. All measurements clustered more closely to
samples from the same individual than samples from any other individual (Figure 3.4). These
results are similar to a previous study that examined the metaproteomes of healthy adult
individuals over time (Kolmeder et al. 2016). The idea of personalized gut metaproteomes
appears to be a distinct feature of adult metaproteomes, as a recent study of preterm infants
showed that the gut metaproteomes of preterm infants did not necessarily cluster by individual
over time (Xiong et al. 2017), indicating that individual specific metaproteomes develop between
early infancy and adulthood.
Overall, these results suggest that there is an underlying continuity in metaproteomes
from the same individual. However, due to the protein variability found within the individuals
even with the most similar metaproteomes (P58 and P68), any real observations of functional
similarity between samples are likely more meaningful by observing common identifiers of
function, such as KEGG orthologous groups, instead of the individual taxa, genes, or proteins.
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Figure 3.3: Variation in the protein groups identified across time and individuals, and how that variation decreases
with functional groups. (A) Shows the number of microbial protein groups that were observed across all time points,
more than one time point, and only one time point for each individual. (B and C) Show the same thing but for
KEGG orthologous groups and GoMixer modules respectively. (D) Highlights the percentage of microbial protein
groups, KEGG orthologs, and GoMixer modules that are found across all individuals, more than one individual, and
only one individual.
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Figure 3.4: Heatmap illustrating the hierarchical clustering of the spearman correlation coefficient between mass
spectrometry runs.

3.3.3 Description of the Seven Microbial Proteins Identified in All Samples
While variation was observed within individuals at the protein group level, it was even
higher between individuals. Out of 14,850 protein groups, only 60 were identified in all samples.
Of those protein groups, 53 were human, and the remaining 7 were microbial. All of these
microbial protein groups mapped to the genus Bacteroides, and, in most cases, these protein
groups were relatively low abundance in the sample, often having less than 100 spectral counts
(Figure 3.5).
All 7 of these protein groups were queried for their known function and conserved
domains using UniProt and InterPro Scan respectively (Finn et al. 2017, Pundir et al. 2017,
The UniProt Consortium 2017) (Figure 3.6).
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Figure 3.5: Abundance across time of the seven protein groups that were consistently observed across all
samples.

Three of these protein groups (104293, 93252, 16954) were found to be related to metabolism.
ProteinGroup_104293 had the most spectral counts and contained two domains related to
Glyceraldehyde 3-phosphate dehydrogenase, which catalyzes one of the reducing steps in
glycolysis. ProteinGroup_16954 contains a FAD binding domain and is annotated as a succinate
dehydrogenase/fumarate reductase subunit, which reduces fumarate into succinate or oxidizes
succinate into fumarate, and according to KEGG is involved in a variety of microbial metabolic
processes, including the TCA cycle, short-chain fatty acid metabolism, carbon fixation, and
carbon metabolism (Kanehisa et al. 2017). ProteinGroup_93252 is annotated as phosphoserine
aminotransferase, which according to KEGG is a component of the transition from Glycerate 3phospate to serine and vice versa, and as a result, plays a role in the degradation and biosynthesis
of amino acids. Together these three protein groups cover a wide range of microbial metabolism,
including central metabolism, fermentation, and amino acid metabolism. Of the remaining four
protein groups, ProteinGroup_253057 is annotated as a L5 ribosomal protein, while protein
groups 28742, 171203, and 3177 are proteins of limited known function with low-quality
annotations based on their domains. ProteinGroup_28742 could potentially be an antigen. All the
sequences that make up this protein group contain a tetratricopeptide repeat domain. This domain
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Figure 3.6: Example InterPro Scan result for 7 protein groups found across all Crohn’s disease study samples.
Specifically, InterPro Scan Result for ProteinGroup_104293 representative sequence. Sequence submitted
2/27/2018. Revealed domains IPR020828 and IPR020829 which are the NAD(P) binding and catalytic domains
respectively for Glyceraldehyde 3-phosphate dehydrogenase.

is a common domain often involved in protein-protein interactions and is an important
component of several virulence factors among other types of proteins (Cerveny et al. 2013).
Along those lines, the submitted name for one of the perfect hits in UniPropt for the sequences
clustered under ProteinGroup_28742 was “Immunoreactive 53 kDa antigen PG123”. Further
research is necessary to characterize the function of these sequences fully. The sequences
clustered under ProteinGroup_3177 contained TonB dependent receptor domains and are likely
to be a part of the SusC/RagA family. Interestingly, TonB and SusC were shown to be
significantly more abundant in ileal Crohn’s disease in a previous publication (Erickson et al.
2012). The UniPropt hits to the sequences clustered under ProteinGroup_171203 were typically
either “Uncharacterized protein” or “NifU-related domain containing protein”. Linking from the
UniPropt annotation to the InterPro annotation revealed that the sequences clustered under this
protein group were homologous to the domain labeled IPR002871. This domain is reported to be
the N-Terminal of NifU, which contains a 2Fe-2S cluster, and is implicated in nitrogen fixation
systems, although the exact biochemical function remains unknown (Ouzounis et al. 1994, Finn
et al. 2017). A homolog to this domain was highlighted previously as a core human gut
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metaproteome protein (Kolmeder et al. 2012). Given its robust observation in gut metaproteome
studies, further insight into the function of this family of proteins could reveal novel insight into
gut community function. The realization that almost half of the proteins identified across all
samples in our database remain poorly characterized highlights the challenge of using proteomics
to understand microbiome function when many if not most of the protein sequences remain
poorly understood
3.3.4 Assignment of KEGG Orthologous groups reveals remarkable functional redundancy
among protein groups
KEGG can be used to infer the functional and taxonomic association of protein groups
based on the biochemical function of the orthologous groups (KO terms) (Aoki-Kinoshita and
Kanehisa 2009), and was employed here to classify and interrogate the metaproteome
information. For greater than 99% of protein groups, all the amino acid sequences associated
with that protein group mapped to the same KEGG orthologous group. Similarly, for greater than
99% of all protein groups, all the amino acid sequences in that group mapped to the same
bacterial phylum. This trend was not true for other lower taxonomic levels. For this reason, the
seed protein’s Ghost KOALA KO and phylum annotation was used for all subsequent analyses.
This was deemed to be the most accurate possible function and taxonomy that could be assigned
to each protein group.
An average of 165,451 ORF’s per protein database were assigned a KO term. This
translated into an average of 5,504 predicted KO terms per individual, indicating high functional
redundancy across protein sequences. Similarly, this high functional redundancy was also
observed across identified protein groups. Of the identified protein groups, 10,172 were assigned
a KO term, but this only amounted to a total of 1,573 KO terms. These results are consistent with
the concept that many of the different protein groups identified likely have the same function.
This is supported by the much more expansive HMP project, which reveal similar available
metabolic functions despite varied taxonomy (The Human Microbiome Project 2012).
Within an individual, 16% of the KO terms predicted by each individual’s protein
database had protein evidence in at least one of their five samples. For context, less than 2% of
the protein groups predicted for each individual had protein evidence in at least one sample. The
majority of the observed function was centered around four phyla: Firmicutes, Bacteroidetes,
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Actinobacteria, or Proteobacteria. These phyla represented the greatest percentage of the total
number of KO terms predicted by each sample’s respective protein database. Similarly,
Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria, along with Verrucomicrobia were
the most represented phyla in previous human gut metaproteomic studies (Kolmeder et al. 2016,
Tanca et al. 2017). Although they were observed in this study, Verrucomicrobia did not represent
a significant proportion of the identified protein groups. This could be related to compromised
health state of the individuals in the current study as compared to the other studies of healthy
individuals. While not as dominant as the other four phyla, protein groups associated with
Fusobacteria and Euryarchaeota in P58 and P33, respectively, represented an uncharacteristically
high percentage of the total number of KO terms predicted by their associated protein databases.
Variability between samples decreased when the qualitative analysis was constrained to
the KO term level. Between individuals, 25% of the KO terms identified across all samples were
seen at least once in every individual. There was also lower intra-individual variability. A greater
percentage of the total number of detected KO terms in each individual were also found across
time when compared to the protein groups (Figure 3.3). These followed essentially the same
trend as the protein group level observations, with P104, P33, and P92 being more variable than
P58 and P68 (Figure 3.3). This suggests two conclusions: the trends in terms of the most
variable individuals across time hold true through to the KO term level, and there is overall less
qualitative variation between samples when focusing on functional groups instead of protein
groups (Figure 3.3).
3.3.5

Inferred metabolic modules demonstrate persistence of metabolic function in a
dynamic microbiome
To expand the search for functional similarity between samples, the metabolic dynamics

of this metaproteomic dataset were explored using a map of human microbiome derived
metabolic modules created by the Raes lab (Vieira-Silva et al. 2016), which represent a set of
reactions responsible for the conversion of one compound to another and are inferred via enzyme
evidence from the metaproteomic datasets. This metabolic map is available in an online tool
called “GOmixer” at http://www.raeslab.org/gomixer/, and is illustrated for this study in Figure
3.7. 116 out of a total of 133 metabolic modules in “GOmixer” were inferred for specific phyla
using the Ghost KOALA annotations for each protein group. A variety of phyla contributed
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proteomic evidence for these modules; however, most of the inferred modules were populated
with protein groups that originated in Firmicutes, Bacteroidetes, Proteobacteria, or
Actinobacteria. Two or more phyla provided evidence for most of the modules observed in
Figure 3.7, where the green lines indicate modules that have protein evidence in two or more
phyla, and the red lines indicate modules that have protein evidence in all four of the main phyla
described above. Together these modules indicate protein evidence for high redundancy in
metabolic function between gut microbiome phyla.
An inspection of the inferred modules reveals several interesting points about the gut
microbiome’s metabolic function in these five individuals. First, despite substantial variation in
the protein groups observed in each sample, these modules demonstrate persistence of metabolic
function across time and individuals. 69 modules were observed in all individuals, of which 18

Figure 3.7: Metabolic map of all the GOMixer modules rendered in the GOMixer web application. Highlighted lines
represent all the modules that were inferred with peptide evidence in at least one sample. Line thickness represents
how many samples the module was observed in with the thickest lines representing modules that were represented
across all samples, the medium thickest lines being represented by modules inferred in all individuals, and the least
thick lines representing modules not seen in all individuals. Red colored lines represent modules that were observed
in Firmicutes, Actinobacteria, Bacteroidetes, and Proteobacteria. Green lines represent modules that were observed
in at least two of the phyla. Black lines represent modules only represented in Firmicutes. Yellow lines represent
modules only observed in Bacteroidetes. Purple lines represent modules only represented in Proteobacteria. Two
modules that were unique to other phyla were MF0027 inferred in Euryarcheota and MF0010 inferred in
Fusobacteria. These were colored beige and orange, respectively.
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were observed in all samples. Tracking through these 18 modules reveals a clear path from
carbohydrate, lipid, and amino acid degradation to central metabolism and finally the production
of fermentation products (Figure 3.7). Second, this persistence of function is redundant across
multiple phyla, but was not always observable in the same sample. All 69 modules except for
one were observed in two or more phyla, and all of the 18 modules observed across all samples
were observed in two or more phyla, but not always in the same sample. In some cases, the
protein evidence for a module comes from one phylum but then changes to another phylum at a
different time (Figure 3.8). Third, the gut microbiome metabolism is not driven by a set of
discrete linear pathways, but a web of interconnected reactions facilitated by a network of
enzymes that connect multiple molecules across multiple pathways. For example, the identified
protein groups suggest that lactose (MF0048) degrades into glucose before following the
classical glycolysis pathway. In contrast, glycerol (MF0107, MF0108, MF0109) and fucose
(MF0124) degrade into glyceraldehyde 3-phosphate, which is the precursor to the pay-off phase
of glycolysis. Similarly, protein enzyme pathway detection suggests that threonine degradation
(MF0029 and MF0030) skips glycolysis by degrading directly into Acetyl-CoA and other
fermentation products, including propionate and formate. These modules represent a major
portion of the metabolic function of the gut microbiome. The population of these modules from
the measured proteomes provides evidence for microbial-driven degradation of complex
molecules across multiple samples, including all 20 amino acids, and a large repertoire of
carbohydrates, such as starch, fucose, xylose, arabinose, lactose, and glycerol. Degradation
modules connect to energy producing modules such as glycolysis, glyoxylate bypass, and
fermentation, for which there was consistent protein evidence. These energy-producing modules
culminate into a variety of gut relevant metabolites, including pyruvate, acetyl-CoA, succinate,
formate, propanoyl-CoA, CO2, acetate, butyrate, and propionate.
The metaproteomic experimental evidence for these specific metabolic modules reveals a
detailed functional view of the gut microbiome ecosystem, in which microbes acquire energy by
degrading complex molecules from both the host and the host’s diet, and then this degradation
process ultimately leads to metabolites, such as butyrate, acetate and propionate, that the host can
use for energy. It appears that the majority of this metabolic function is not specific to an
individual bacterial strain, species, genus, or phylum but is instead shared between phyla.
Furthermore, the phylum driving an individual module, as evidenced by proteomic data, can
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Figure 3.8: Trends by phylum in modules pertaining to degradation of food products that were consistently observed
across all samples. MF0029 and MF0030 represent different pathways that degrade Threonine the only amino acid
degradation pathway that was seen across all samples. MF0048 represents Lactose degradation. MF0062 represents
starch degradation a critical polysaccharide food source that comes from plants. MF0108 represents glycerol
degradation, the only lipid degradation pathway that is observed across all samples. MF0124 represent Fucose
degradation which is a mucosal glycan that the host produces and that the bacteria in the gut microbiome consume.
were observed in two or more phyla, but not always in the same sample.
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change dynamically across time and individuals (Figure 3.8). This manuscript provides a detailed
analysis of a few of these key modules, but the full set of modules that were inferred with
proteomic evidence across time and individuals is detailed in Supplementary Spreadsheet 3 of
Blakeley-Ruiz et al. 2019.
3.3.6 Observation of acetylglucosamine and acetylneuraminate indicate the microbiome can
feed itself at the expense of the host
Detailed analysis of Figure 3.7, and the information in Supplementary Spreadsheet 3 of
Blakeley-Ruiz et al. 2019, prompted interest in two specific modules, MF003 and MF005. These
modules are observed in all individuals across multiple phyla and highlight metabolites that enter
central metabolism at multiple positions in the pathway. Specifically, these modules represent
the degradation of acetylglucosamine and acetylneuraminate into D-Fructose 6-phosphate,
pyruvate, and acetate. Acetylglucosamine and acetylneuraminate are sugar amine hybrids found
in the host mucosal layer, human milk oligosaccharides, and in animal food products that are key
host nutrients, and presumably are used by the gut microbiome as a source of energy (Wang and
Brand-Miller 2003, Marcobal et al. 2011, Tailford et al. 2015). Interestingly, providing N-acetylglucosamine as a supplement has been suggested as a potential method for alleviating
inflammatory bowel disease (Salvatore et al. 2000). MF0003 and MF0005 enter central
metabolism at three separate levels, and merge with each other at N-Acetyl-D-glucosamine 6phosphate, highlighting a simple demonstration of the interconnected nature of gut microbiome
metabolism (Figure 3.9).
Evidence for the presence of MF003 and MF005 was observed across all individuals and
in Firmicutes, Proteobacteria, Bacteroidetes, and Actinobacteria, thereby demonstrating the
persistence of function despite the dynamic nature of the gut microbiome. Evidence for Nacetylneuraminate lyase (K01639) was observed in Firmicutes (P68, P92, P58, and P104),
Proteobacteria (92), and Bacteroidetes (P68, P33, P58, and P104), but not in Actinobacteria.
Evidence for the production of N-Acetyl-D-glucosamine 6-phosphate was limited in both
modules; however, evidence for N-acetylmannosamine-6-phosphate 2-epimerase and Nacetylmannosamine kinase (K00885 and K01788) was observed in Proteobacteria on day 88 in
P92 and in Actinobacteria on day 173 in P104. Similarly, evidence for the phosphotransferase
system (K02802, K02803, and K02804) was only observed in Firmicutes in individuals P68 and
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Figure 3.9: Detailed pathway describing modules MF0003 and MF0005, which together degrade acetylglucosamine
and acetylneuraminate into pyruvate, fructose-6-phospate, and acetate. All the KEGG ortholog terms in this figure
had peptide evidence in our data set. K00656, while not a part of these modules, had proteomic evidence in every
sample of this database, and was the method for converting pyruvate to Acetyl-CoA that there was the most protein
evidence for.
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P104, and in both Firmicutes and Proteobacteria in individual P92. Despite the relatively sparse
evidence for enzymes specifically involved in the production of N-Acetyl-D-glucosamine 6phosphate, mentioned above, there was substantial evidence for enzymes associated with the
utilization of N-Acetyl-D-glucosamine 6-phosphate. N-acetylglucosamine-6-phosphate
deacetylase (K01443) was observed across all individuals in Firmicutes (P68, P92, P33, P58,
P104), Proteobacteria (P92), Actinobacteria (P33, P58, P104), and Bacteroidetes (P68, P92,
P33, P104). Glucosamine-6-phosphate deaminase (K02564) was also observed across all
individuals in Firmicutes (P68, P92, P33, P58, P104), Actinobacteria (P68, P58, P104),
Proteobacteria (P92), and Bacteroidetes (P68, P92, P33, 58, P104). Together these enzymes
show consistent presence of both modules across all individuals.
Of interest, N-acetylglucosamine-6-phosphate deacetylase (K01443) was highlighted as a
core enzyme in a previous healthy cohort study (Kolmeder et al. 2016). Combined with the fact
that this enzyme is found across multiple phyla, this suggests that it may be a key source of
energy for gut microbiomes. In contrast, K01639 and K01639 were also observed in all
individuals in this study, but were not in the core set from this previous study, possibly
suggesting a potentially different utilization of D-Glucosamine 6-phosphate.
These enzymes serve as a representative case for both the redundant and dynamic nature
of microbiome metabolic functions. For example, most of these enzymes were observed in one
of the four phyla at least once, but the modules were not always inferred in the same phyla across
individuals. These modules also highlight the web-like nature of gut microbiome metabolism.
The degradation of acetylglucosamine and acetylneuraminate connect at N-Acetyl-Dglucosamine 6-phosphate, and together these modules release products into central metabolism at
three separate points: D-Fructose 6-phosphate, pyruvate, and acetate. D-Fructose 6-phosphate is
a precursor to the pay-off phase of glycolysis. Pyruvate is the end product of the pay-off phase
of glycolysis and is the starting point for a variety of fermentation pathways as well as the TCA
cycle and glyoxylate bypass. Acetate is one of the three main short chain fatty acids produced by
the gut microbiome, and is a source of energy for both the host and the microbiome. It can be
converted to Acetyl-CoA at the cost of ATP or via transferase with the help of butyryl-CoA or
propanyl-CoA (Vanderwinkel et al. 1968). Conversion by transferase produces butyrate and
propionate which can also be converted by the host into energy. Together these modules
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represent a sample case of how many different phyla contain similar metabolic modules that can
utilize host derived molecules, such as acetylglucosamine and acetylneuraminate.
3.3.7 Observation of short-chain fatty acid associated modules indicate that the host is fed by
a changing set of pathways and bacteria
Just as acetylglucosamine and acetylneuraminate feed the microbiome, short-chain fatty
acids, particularly acetate, propionate, and butyrate, are thought to be one of the primary methods
by which the gut microbiome feeds its host. “GOmixer” highlights 9 modules as acetate
(MF0113), propionate (MF0121, MF0122, MF0123, MF0125, MF0126), or butyrate (MF0114,
MF0116, MF0117) producing. All these modules were observed with peptide evidence in at least
one sample. Some of these modules do not represent the direct production of short-chain fatty
acids, but instead, represent the production of precursors to CoA-transferase and kinase
reactions. Only MF0113, MF0116, MF0117, MF0125, and MF0126 connect the direct
production of short-chain fatty acids via CoA-transferase, kinase, or a similar reaction. The
average abundance of the KO terms in each module divided by the total depicts the persistence
of function amidst a dynamic microbial ecosystem. Particularly propionate and acetate producing
modules persist across time and individuals while being driven by different phyla or modules
(Figure 3.10). Evidence for enzymes involved in the direct production of butyrate was observed
only in individuals P58, P68, and P92. This supports previous proteomic studies, which indicated
that the abundance of butyrate-producing enzymes is significantly lower in patients with Crohn’s
disease (Erickson et al. 2012).
Utilizing the KEGG orthologous groups that had representation in the modules and their
associated reactions in KEGG, a reaction network was manually produced (Figure 3.10). This
network highlights evidence for dynamic and interconnected microbial metabolic function.
Acetate production via acetate kinase (MF0113) had peptide evidence across all individuals.
One set of enzymes can produce acetate via a two-step process that involves first converting
acetyl-CoA to acetyl-phosphate (K13788, K00625, K15024) and then converting acetylphosphate to acetate (K00925), producing ATP in the process. These reactions are reversible
(Wolfe 2005), and there was evidence for the enzymes involved in both steps across all
individuals and almost all the samples. According to the KEGG database and the literature, given
propanoyl-CoA as the starting material, this module will also produce propionate, providing
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peptide evidence for the potential production of propionate across all individuals as well
(Heßlinger et al. 1998). This highlights the interconnectedness of gut metabolism, as the same
enzymes can plug into different fermentation routes of the broader metabolic network given
different starting material.
There was also limited evidence for a propionate specific kinase (K00932) in individual
P92, and the production of propionate via CoA transferase (K01026) in P33 and P58. Production
of butyrate or propionate by CoA-transferase requires the transfer of the coenzyme from butyrate
or propionate to another acid typically acetate, but it could also be lactate. This is an
interconnected process. For example, propionate CoA-transferase, K01026, according to KEGG
reactions, transfers CoA between lactate, propionate, or acetate to produce lactoyl-CoA, acetylCoA, or propanoyl-CoA. K01026 further highlights the interconnectedness of gut microbiome
metabolism as Proponyl-CoA is converted into propionate by converting acetate or lactate into
acetyl-CoA or lactoyl-CoA respectively, and vice versa.
Butanoyl-CoA can be converted into butyrate by two main methods, presenting a good
example of the dynamics of microbial metabolic function. Acetate CoA-transferase, (K01034
and K01035) converts butanoyl-CoA to butyrate by converting acetate into Acetyl-CoA and vice
versa. Butyrate kinase is a two-step process that involves the conversion of Butanoyl-CoA to
Butanoyl-Phosphate (K00634), followed by the production of butyrate via the kinase (K0929). In
each individual, except P92, which had no peptide evidence of butyrate production, only one
method or the other was observed. P58 and P68 had evidence for the production of butyrate via
transferase, and P104 and P33 had evidence for the production of butyrate via kinase. Albeit, P33
only had peptide evidence for K00634, but not the actual kinase. This presents an example of
persistence of function despite a dynamic gut microbiome. There was peptide evidence for
butyrate production across most individuals; however, half of the individuals had peptide
evidence for a different module than the other half. Although not typically included in
discussions about short-chain fatty acid production in the gut, it should be noted that peptide
evidence for the production of the smallest short-chain fatty acid, formate, was observed via
K00656 across all samples, thus providing persistent peptide evidence for the conversion of
pyruvate to acetyl-CoA across a variety of phyla.
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Figure 3.10: Representation of direct routes to short chain fatty acids and acetyl-CoA with proteomic evidence.
All KEGG Ortholog terms mentioned in this figure had proteomic evidence in at least one sample, although
many had evidence across all individuals and most samples. For example, K00656 had proteomic evidence in all
samples and in Firmicutes, Actinobacteria, Proteobacteria, and Bacteroidetes, but not always at the same time.
These enzymes form a sizable representation of the pathways to these metabolites with proteomic evidence;
however, not all enzymes that can produce these molecules are included.
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K00656 has been consistently observed in previous metaproteomic studies, along with
acetate producing enzymes K00625 and K00925, (Kolmeder et al. 2016, Tanca et al. 2017)
indicating that acetate production via these enzymes may be ubiquitous regardless of human host
health status. Kolmeder et al. 2016, highlights Propionate CoA-Transferase and Butyryl-CoA
dehydrogenease as being core enzymes, although these are not observed across all individuals in
this dataset. This correlates to previous research which has shown that short-chain
fatty acid producing proteins especially butyrate, are less abundant in Crohn’s diseased patients
(Erickson et al. 2012).

3.4 Discussion
Measurement of the metaproteomes of Crohn’s diseased patients (all post resectionsurgery) over the course of a year revealed substantial variability in the protein groups observed
across time and individuals. There was significant qualitative variability even within the same
individuals, which supports the dynamic nature of the microbiome’s composition, as was
previously observed in the same individuals (Halfvarson et al. 2017). The gut metaproteomes of
these individuals were distinctly personalized, with some individuals exhibiting less variability
across time than others.
This study has demonstrated that despite this variability, many metabolic functions are
consistently observed across diverging sequence space, suggesting that sequential variability
may not be a good indicator of metabolic functional variability. Individual KO terms were found
to be more consistent across time and individuals than protein groups. The majority of KO terms
observed originated from Firmicutes, Actinobacteria, Proteobacteria, and Bacteroidetes, and
when placed in a metabolic context, consistent and somewhat redundant metabolic functions
relating to the degradation and fermentation of food products were observed.
Although this study did not focus on taxonomical resolution below the phylum level (for
reasons noted above), it is evident that almost all the functions observed across all individuals
were observed in multiple phyla. This provides compelling evidence that these functions are not
specific to any one phylum, genus, or species, and may suggest that functional redundancy
across taxa is a hallmark of robust gut microbiome stability. These modules reveal the
interconnectedness of gut microbiome metabolism, suggesting that overall gut microbiome
operation should be viewed in a network context focused on metabolic function. By combining
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metagenome resolved genomes (MAGs) with metaproteomes it could be possible in the near
future to acquire genome constrained proteomes for complex communities providing a
framework by which proteome guided metabolic reconstruction could be done. Although using a
much broader taxonomical level due to technical constraints, this chapter provides a first look at
how metabolic function is shared across taxa, and persists despite different identified protein
groups between samples, and a taste of what MAG driven community proteomics could look like
in the near future.
Although this study was not designed to directly contrast healthy individuals versus
individuals with Crohn’s disease, these specific diseased individuals have been contrasted with
healthy individuals in a prior study (Erickson et al. 2012), and thus were selected here to
encompass the widest range of taxonomical variability. The data revealed that microbiomes of
these post-surgery individuals had significant variability in taxa, genes, and proteins; however,
key metabolic modules associated with central metabolism were seen in all samples, even though
the phyla of origin was often different. End-point metabolic modules, such as short-chain fatty
acid production, were seen intermittently across samples, although only butyrate-producing
modules were absent in one individual.
Specifically, there was evidence that there is persistent and phylum-redundant metabolic
functional stability in these individuals. This approach provides a distinct observational
viewpoint of following metabolic reactions and compounds/enzymes as a marker of overall
microbiome activity, even if populations and specific genes/proteins vary.
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4.1 Introduction
Disruption of the gut’s microbial composition is associated with a variety of metabolic
and immunological diseases including diabetes (Stewart et al. 2018), obesity (Pfalzer et al.
2015), inflammatory bowel diseases (Erickson et al. 2012), irritable bowel syndrome (Rajilić–
Stojanović et al. 2011), and necrotizing enterocolitis (NEC) (Stewart et al. 2016). Though
specific taxa have been associated with these diseases, e.g., Klebsiella in the case of NEC (Olm
et al. 2020), the inherent variability in gut microbiome composition across individuals makes it
challenging to observe specific microbial taxa correlated with a disease consistently. While
similar phyla are present across individuals, a recent investigation of over six hundred twins in
the UK showed the average microbial species to be found in only two individuals (Visconti et al.
2019). Despite this inherent variability in composition, microbial function appears to be more
conserved between individuals (Blakeley-Ruiz et al. 2019). An alternative and less explored
approach is to examine changes in gut microbiome function with regards to these diseases
regardless of taxonomic composition.
At birth, the gut microbiome is sparsely populated but rapidly increases in community
complexity over the first two years of life before plateauing (Yatsunenko et al. 2012). Early in
life, particularly in preterm infants, the microbial community remains more varied. Within an
individual preterm infant, the gut microbiome can be as different from day to day as it is between
individuals (Xiong et al. 2017). Despite this variance, preterm infants, because of their less
complex gut microbiomes, have been a useful proving ground for exploring leading-edge
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techniques to study the microbiome. The extraction of individual genomes from fecal sample
metagenomes was developed and improved using preterm infants (Vieira-Silva et al. 2016).
Metaproteomics techniques have been combined with genome-level resolution metagenomic
techniques to explore protein expression in these genomes (Brooks et al. 2015, Young Jacque et
al. 2015, Xiong et al. 2017). Mass spectrometry-based metaproteomics can detect and quantify
thousands of microbial proteins from an environmental sample (Verberkmoes et al. 2008).
Metaproteomics compliments metagenomics by measuring the functional activity of the cell,
while metagenomics only measures the functional potential of the cell (Kleiner 2019).
Metaproteomics also detects host proteins in conjunction with microbial proteins providing an
avenue by which host function can be observed alongside microbial function (Xiong et al. 2017).
One of the most extensive integrated metagenomic and metaproteomic studies to date is a
time-course study conducted on a cohort of preterm infants that did or did not develop NEC
(Brown et al. 2018). Although Klebsiella was observed to be more abundant in NEC afflicted
infants, no specific species detected in NEC was found to be in all infants that developed NEC.
Several proteins, however, were found to be significantly different in abundance between infants
that developed NEC than those that did not. A more recent analysis of just the metagenomic data
from this study used gradient boosted machine learning to determine the most significant
predictors of NEC. The top predictors found were bacterial replication rate, KEGG metabolic
modules, and Klebsiella; however, the study did not go into much detail about the predictive
metabolic modules(Olm et al. 2019).
This analysis seeks to explore further the microbial metabolic function of these preterm
infants by exploring the specific metabolic reactions, coded by the KEGG ortholog annotations,
of proteins previously measured in (Brown et al. 2018). Reaction to compound data from KEGG
can, in turn, be used to build metabolic networks (Huss and Holme 2007). In this manuscript, a
reaction is defined as the conversion of a specific set of one or more compounds into another
specific set of one or more compounds as described by the KEGG reaction, compound, and
glycan databases (Aoki-Kinoshita and Kanehisa 2009, Kanehisa et al. 2016). For example,
R01688 represents butyrate kinase, which catalyzes the conversion of butanoylphosphate to
butanoic acid, converting ADP to ATP in the process. In this analysis, it was hypothesized that
combining metagenomic data with metaproteomic data could produce highly connected
metabolic networks (Figure 2.3) and that the reactions that make up these networks would be
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more conserved across individuals than the individual proteins or orthologous groupings that
predict them. These reactions could be assigned to the host or the microbiome, and reactions
supported by the literature could be shown to differentiate between NEC and non-NEC infants.
Finally, the metabolic networks could be used to extract pathways of reactions over or underrepresented in NEC.

4.2 Methods
4.2.1 Data acquisition
An integrated metaproteomics/metagenomics dataset describing 17 preterm infants over
the first approximately 80 days of life was used for this study. Six of the infants eventually
developed NEC. For each infant, between 3 to 12 samples were compiled for a total of 91
samples. All samples were collected between Day of Life (DOL) 6 to 86 and covered a
gestational age range of 25 and 39 weeks. All metaproteomes were collected in technical
duplicate using a 24 hour 11 salt-pulse 2D-LC-MS/MS method on an orbitrap-elite mass
spectrometer (Xiong et al. 2017, Brown et al. 2018). Raw proteome data from all infants except
one have been published previously (Xiong et al. 2017, Brown et al. 2018). Through email
communication with the authors of (Brown et al. 2018), predicted protein sequences from 204
metagenomes with relevant metadata were compiled as well, between 5 and 22 per infant.
4.2.2 Protein database construction and annotation
Predicted protein sequences derived from all the metagenomes available for each were
compiled into infant specific protein databases and clustered at 100% sequence identity using cdhit to remove redundancy (Fu et al. 2012). All predicted proteins from all metagenomes were
also compiled into a combined database and clustered at 100% sequence identity to create a
sequence-specific identifier to link identical sequences between individuals. The scaffolds from
the metagenomes had previously been binned into metagenome assembled genomes (MAGs)
(Brown et al. 2018). These MAGs had been assigned a subspecies level taxonomy and had been
grouped into subspecies groups using a 98% average nucleotide identity (ANI). The original
scaffold of each predicted protein was retained in each protein identifier and used to match each
protein to its subspecies group if one was available. Proteins with a subspecies group were
assigned the genus of that subspecies group. Proteins with no corresponding MAG were assigned
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as unknown since it is imprecise to determine the genus of origin of a single protein sequence
without the context of other sequences from the same genome. KEGG orthology terms were
assigned to protein sequences using the eggNOG database’s internal annotator emapper (version
1.0.3-3-g3e22728), default parameters except for -m diamond, which uses the diamond instead
of the hmmer algorithm to assign orthology (Kanehisa et al. 2016, Huerta-Cepas et al. 2017).
4.2.3 Protein inference
All mass spectrometry raw files were converted to mzML format using msconvert
(proteowizard release 3.0.11252) (Chambers et al. 2012). Each infant specific microbiome
protein database was combined with a human proteome, and a list of common contaminants to
use for spectral matching. Each metaproteome sample was collected in technical duplicate, and
each of these measurements was searched using the crux framework (v. 3.2-0bf523f) (McIlwain
et al. 2014). The databases were indexed using tide-index (--missed-cleavages 2, --mods-spec
C+57.02146,2M+15.9949 --clip-nterm-methionine T --decoy-format protein-reverse), the mass
spectra were searched against the index using tide-search (--compute-sp T, --exact-p-value T, -score-function both, --precursor-window 10, --precursor-window-type ppm), results were quality
scored using percolator (--spectral-counting-fdr 0.02, --test-fdr 0.02, --train-fdr 0.02, --protein
T), and quantified with NSAF values using spectral-counts (--parsimony simple) (Käll et al.
2007, Serang et al. 2010, Diament and Noble 2011). A protein was inferred if it had a least 1
unique spectrum at a peptide spectral match false discovery rate (FDR) q-value of less than 0.02
and a fido protein FDR q-value of less than 0.05. Technical duplicate measurements were
combined by averaging the NSAF of proteins detected in both technical replicates. If the sample
was only detected in one replicate, then the NSAF of that replicate was used.
4.2.4 Construction of graph database
Using the R package KEGGREST, reaction, compound, and glycan objects were
downloaded from KEGG (Tenenbaum 2020). These were used to build a bipartite metabolic
graph in which one partite set consisted of reaction, and the other consisted of compounds
(compound and glycan objects). Vertices between partite sets were linked if the compound was a
substrate or product of the reaction. For example, continuing with butyrate kinase, butanoic acid,
C00246, and butanoylphosphate, C02527, were each linked to KEGG reaction R01688, and by
extension, to each other. To this foundational graph, infants, samples, and identified proteins
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were added (Figure 4.1). An edge was created between a protein and a reaction if they shared an
EC or KO number, and an edge was added between a protein and a sample if a peptide from the
sample had been mapped to the protein. Note that samples link to multiple proteins, and specific
proteins may be linked to multiple reactions. For convenience, this graph was built and accessed
as a labeled property graph database using Neo4J (http://neo4j.org).
4.2.5 Data Analysis
KEGG orthologs, reactions, and compounds associated with detected proteins were
extracted from the graph database using Cypher and Py2neo (https://py2neo.org/). Using the
Python pandas package (https://pandas.pydata.org/), proteins, KEGG orthologs, reactions, and
compounds were assessed by how many samples/individuals in which they appeared and
whether they were microbial or host. In addition, the Jaccard index of similarity was calculated
between samples for microbial and host proteins, KEGG orthologs, reactions, and compounds (J
= (A U B)/(|A|+|B|- A U B))(Jaccard 1908). For each sample, a metabolic network was
reconstructed by creating an edge list of reactions to compounds where a protein associated with
a given reaction was present in the samples. To remove high degree connections that do not
reflect the flow of carbon, a list of currency metabolites, such as ATP, was used to remove those
edges. These reactions-to-compound graphs were analyzed for connected components to
identify fully connected paths, and bipartite projections were used to create compound-tocompound and reaction-to-reaction networks using the python-igraph package
(https://igraph.org/python). The number of reactions and proteins over time relative to NEC was
compared using linear mixed-effects models from the R package (lme4), and ANOVA from the
R package (lmerTest). Reactions were quantified in each sample by summed NSAF of associated

Figure 4.1: Structure of baby-sample-protein-reaction-compound graph database
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proteins and by counting the number of proteins detected for each reaction in each sample. Each
of these metrics was normalized by log2 transformation followed by subtracting the mean for
each sample. Reactions were then compared between NEC and non-NEC infants using a linear
mixed-effects model, lmer (Reaction~NEC*Time + (1|Individual), and corrected by BenjaminiHochberg procedure (Q<0.25 for all p-values). Figures were rendered using a combination of
python and R packages seaborn, pandas, ggplot2, and jtools. In-house python scripts conducted
any data processing not associated with a published bioinformatics tool.

4.3 Results
4.3.1 Reactions are substantially more conserved between samples than protein sequences
To build a comprehensive database for protein identification, predicted protein sequences
were compiled from 204 metagenomes independently sampled, sequenced, and assembled from
17 preterm infants, 6 of whom eventually developed NEC (Brown et al. 2018). The combined
protein database of these metagenomes contained a total of 4,350,713 distinct protein accessions,
which clustered into 804,297 non-redundant protein sequences at 100% sequence identity (Li
and Godzik 2006). Variability between samples at the metagenome level was high. The median
number of individuals that a sequence was observed in was one, and the median number of
samples a sequence was observed in was two (Figure 4.2a).
Based on this information, instead of searching against all sequences from all
metagenomes, the metagenomes specific to each individual were compiled to form individual
specific microbial protein databases clustered at 100% amino acid identity to remove
redundancy. These individual specific databases were combined with human and contaminant
databases, also clustered 100% identity, and then searched against 182 technical duplicated
metaproteomic 2D-LC-MS/MS measurements from 91 samples. In total, 439,434 non-redundant
proteins were identified, of which 415,448 were microbial (52% of the total non-redundant
database); however, only a median of 17,794 microbial and 6,996 host proteins was identified
per sample, and, the median microbial protein was only observed in three samples and one
individual (Figure 4.2c).
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Figure 4.2: Observed genes are radically different across samples, but reactions are more conserved.
(a) Histogram shows the number of samples in which each non-redundant protein was sequenced in the
metagenome. (b) Violin plot of the Jaccard index of similarity between samples at the protein, KEGG, reaction, and
compound level. (c-h) Histograms show the number of samples each human or microbial protein, KEGG term, and
reaction was observed in.
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To confirm that KEGG orthologs were more conserved than proteins across samples, and
to show that reactions were further conserved, microbial proteins were annotated with KEGG
ortholog terms using the emapper pipeline from the eggNOG database (Huerta-Cepas et al. 2016,
Huerta-Cepas et al. 2017). These KEGG terms (KO) were used to connect protein identifiers to
reactions, and reactions to associated compounds they convert. Together all this data was used to
build a baby-sample-protein-KO-reaction-compound graph database (Figure 4.1).
Identified proteins were annotated with a total of 14,013 KEGG orthologous groups, of
which 1,882 were shared between human and microbial proteins, and 8,845 were exclusive to
microbial proteins. These KO terms pointed to a total of 4,933 reactions, of which 1,813 were
shared between proteins from the microbiome and the host, and 2,435 were unique to proteins
from the microbiome. The median microbial KO term were observed in 37 out of 91 samples,
and 12% were observed in all samples. The median microbial reaction were observed in 76 out
of 91 samples, 30% were observed across all samples. The compounds catalyzed by these
reactions were even more conserved, with the median compound found in 86 samples and all
individuals, and 40% of compounds having an associated enzyme in all samples, suggesting
multiple types of reactions converting the same compounds. Thus, in a three-step transition from
identified sequence to a specific function, one can observe that specific metabolic functions are
substantially more conserved across samples than their protein sequences of origin (Figure 4.2ce). A similar but less extreme trend is observed with the human proteins (Figure 4.2f-h). This
makes sense since reactions from the host are less likely to be attached to multiple proteins than
reactions from the multiple organisms in the microbiome. Together, these trends support the
hypothesis that discrete metabolic function rather than protein sequence information may be a
meaningful approach for the analysis of sparse microbiome data.
To look at the pairwise similarity in detected proteins, KO terms, reactions, and
compounds between samples, the Jaccard similarity index was calculated between samples for
both the host and microbial versions of each of the metrics (Figure 4.2b). A similar trend was
observed with samples sharing a median 3% of microbial proteins while sharing >70% of
reactions with each other. Host proteins were less extreme, sharing a median 36% of host
proteins between samples and a median 59% of host reactions between samples. These results
show that the trends observed above hold on a pairwise basis, and reactions are indeed more
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likely to be shared between samples, thus suggesting a more stable space for quantitative
comparison between samples.
4.3.2 KEGG annotation of detected proteins enables the generation of connected metabolic
networks
A key goal of this project was to determine if metabolic pathways could be reconstructed
de novo using reaction to compound data derived exclusively from the proteomes in any given
sample. A bipartite reaction-to-compound graph was created for each sample based on the
reactions associated with the annotations of each detected protein. These networks each had a
dominant single connected component. Many of these connections were driven by so-called
currency metabolites, such as ATP, ADP, NAD, NADH, etc. A list of 37 of these types of
metabolites was compiled and removed from the graphs. While this did indeed break some of the
connections, the resultant graphs maintained the same structure with a single dominant
connected component (Figure 4.3a). Using a bipartite projection, each of these bipartite graphs
was collapsed into a reaction-to-reaction graph and a compound-to-compound graph (Figure 4.3b
and 4.3c). By doing a connected component analysis of each graph, it was determined that >80%
of the compounds in each graph were present within the single largest connected component, and
>86% of the reactions were present in the single connected component (Figure 4.3d). This result
indicates that beyond being able to reconstruct pathways, fully connected metabolic networks
can be reconstructed exclusively using metaproteomic data. This offers both the potential of
pathway reconstruction of up-regulated functions and the possibility of metaproteome guided
metabolic modeling. Further analysis of these networks found that the maximum distance
between any compound in the compound to the compound connected component was 20,
suggesting a maximum pathway length of 20 between any two compounds.
4.3.3 Network analysis reveals numerous host-microbe connections
To explore the overall dynamics of the metabolic interaction between the microbiome
and the host, reactions were divided into reactions that were shared between the host and the
microbiome, reactions specific to the host, and reactions specific to the microbiome. 13% of
reactions were found to be unique to the host in all samples, while 36% were shared between the
host and the microbiome, and 49%, were unique to the microbiome (Figure 4.4). Many reactions
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that were shared, however, were not shared in all samples. Within any sample, the percentage of
reactions exclusive to the microbiome ranged from 45% to 75%, and the percentage of reactions
exclusive to the host ranged from 9% to 25%. The percentage of reactions associated with the
microbiome significantly increased over time, while the percentage of reactions shared or unique
to the host decreased over time. Interestingly, further analysis of these results showed an
opposite trend for infants that eventually developed NEC, with the percentage of microbial
reactions decreasing over time, while the percentage of host proteins increased over time (Figure
4.5). This result was only observed when Baby 61, the only NEC infant with data past day of life
80, was included in the analysis.
To determine if host, shared, or microbial reactions were more likely to be connected to a
similar reaction type or a different reaction type, the number of host-host, host-microbe, hostshared, or microbe-shared edges in each sample’s reaction-reaction network was calculated. On
average 26% of edges containing a host reaction were found to be host-host, while 52% were
host-microbe. In contrast, on average, 51% of edges with a microbial reaction were microbemicrobe, while 18% were host-microbe. Exploring these trends among infants that did not
develop NEC over time revealed a significant increase in the percentage of microbe-microbe
edges relative to the number of total microbe edges (Figure 4.5). Similarly, the percentage of
host-microbe edges relative to total host edges also increased over time. Conversely, the
percentage of host-microbe edges relative to total microbial edges and the percentage of hosthost edges relative to total host edges decreased overtime. Interestingly, infants that developed
NEC showed an opposite trend, but only when baby 61 was included in the analysis. This result
provides further evidence that ordinarily, the host cedes functionality overtime to the
microbiome, and that NEC may have a different trajectory.
To quantify the redundancy of reactions across taxa and samples, the number of genera
including the host associated with each reaction was calculated both across samples and within
each sample. Nineteen percent of all reactions were exclusive to one genus when considering
both host and microbial reactions. This number dropped to six percent when host-specific
reactions were excluded, and reactions shared between host and microbiota were included.
Shared reactions are not exclusive to one genus since they include the genus Homo and at least
one other microbial genus. When these shared reactions were excluded as well, it was found that
eleven percent of reactions were unique to at least one genus across all samples. Together this
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Figure 4.3: Reaction to compound metabolic networks reveal primarily a single connected component. (a)
Representative compound to reaction graph for a single sample, S_3_25.1. (b) Reaction to reaction graph of the
same sample after a bipartite projection. (c) Compound to compound graph of same sample after a bipartite
projection. (d) Categorical dot plot depicting the number of nodes in the largest component divided by the total
number of nodes for both the compound and reaction graphs. Red nodes represent reactions and blue nodes
represent compounds.
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implies that across all the metabolic networks, only 6% of reactions were unique to specific
reactions across time, suggesting that most reactions can be catalyzed by more than one genus.
Temporally, a greater percentage of reactions were unique to a single genus within any
one sample. A mean 35% of reactions in any one sample were unique to a single genus when
considering the host, and a mean 22% of reactions were unique to a single genus when excluding
reactions derived only from host proteins. Analyzing these two data sets, it seemed that overall,
the number of reactions unique to one genus decreased across time (Figure 4.5). When including
the host, this appeared to be driven by infants that did not develop NEC, providing further
evidence for the idea that the host cedes function to the microbiome as time progresses.
Interestingly, when excluding host-specific reactions, an opposite trend was observed, where the
downward trend was driven by infants that developed NEC. Potentially this could be driven by
several microbial genera responding to the gut conditions that lead to NEC.

Figure 4.4: A substantial number of reactions are shared between host and microbiome. (a) Reaction to reaction
graph for S_3.25.1 showing microbial (purple), shared (orange), and host (green) reactions. (b) Venn diagram
showing number of reactions that are microbial, shared, or host across all samples.
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4.3.4 Linear mixed-effects models reveal reactions associated with the development of
Necrotizing Enterocolitis
To explore the functional differences between infants that developed NEC versus infants
that did not, KEGG reactions with protein evidence were quantified via two methods. First, the
NSAF abundance of all proteins associated with KEGG reactions was summed for each sample,
referred to as NSAFk. Second, the number of proteins detected for each KEGG reaction was
counted for each sample, referred to as PN. Both quantifications were similarly normalized, and
missing values imputed. Though these two metrics may appear similar, they measure different
things. NSAFk, as a protein abundance metric, measures at least three things: number of proteins
expressed that are annotated with the reactions, the abundance of the organisms producing the
proteins, and the relative abundance of the protein within the organisms. PN measures only one
thing, the number of distinct proteins sequences above the limit of detection, annotated with the
reaction. Thus, NSAFk is an abundance metric driven by multiple factors, while PN is more
reflective of a bulk microbiome functional transition and this difference was visible in the
results.
To account for random effects caused by multiple measures from the same individual and
the effect of time, each reaction was tested using a linear mixed-effects model with NEC and
time as interacting fixed effects, and the infant of origin as a random effect. All p-values were
compared using a Benjamini-Hochberg procedure, and p < 0.05 was found to be equivalent to a
Q < 0.25. This was set as the significance cutoff along with an absolute log2 fold change of 0.5 or
higher.
This approach allowed the identification of reactions that significantly increase or
decrease over time. Using the PN, 2,583 reactions were found to be significantly increasing or
decreasing across time, and 301 were found to be differentially changing across time between
NEC and non-NEC. Among reactions that were significantly changing over time, all but six
decreased in the relative number of proteins across time. This suggests a general trend toward
decreasing the relative number of proteins per reaction over time. An explanation for this could
be the increase in the number of reactions across time, while the number of proteins remains
constant, suggesting fewer proteins available for each reaction. Using NSAFk, there was a more
even distribution, 885 reactions were seen to be increasing or decreasing across time, of which
39% were decreasing over time. Reproducing the results observed in Brooks et al. 2015 for one
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Figure4.5: Ratio of host to microbial reactions changes across time. Regression plots showing a variety of metrics
across time shaded region is 95% confidence interval as predicted by jtools. (a) Ratio of host reactions relative to
total reactions across time. (b) Ratio of microbial reactions relative to total reactions across time. (c) Number of
reactions unique to a genera/relative to total reactions across time. (d) Number of reactions unique to a genera, when
only considering microbial or shared reactions. Using all the reaction to reaction networks it was calculated how
many edges were microbe to microbe or host to host. (e) Number of host to host edges relative to total number of
edges with a host reaction. (f) Number of host to microbe edges relative to the total number of edges with a host
reaction. (g) Number of microbe to microbe edges relative to total edges with a microbial reactions. (h) Number of
microbe to host edges relative to total number of edges with microbial reactions.
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infant, reactions associated with beta-oxidation decreased across time, while reactions associated
with glycolysis increased across time, suggesting a transition from aerobic to anaerobic
metabolism (Brooks et al. 2015). The primary purpose of this analysis, however, was to
determine reactions that were consistently more or less abundant across time in infants that
develop NEC relative to those infants that did not develop NEC. The remainder of the analysis
will focus on those.
When considering reactions significantly distinct between NEC and non-NEC infants,
different but complementary trends were observed between the two-abundance metrics (Figure
4.6). Using NSAFk, 347 reactions were observed to be different in abundance between NEC and
control, of which 95% were more abundant across time in non-NEC infants than in infants that
developed NEC, and 68% were host or shared between the microbiome and the host. Using PN,
107 reactions were observed to be significantly different between non-NEC and infants that
eventually developed NEC. Ninety-seven percent of these had more relative protein in NEC than
in non-NEC, and seventy-one percent were exclusive to the microbiome. This difference may be
driven by the inherent differences in what is being quantified between the two metrics.

Figure 4.6: Reactions significantly different between NEC and non-NEC. (a) –log10(p-values) versus log2(foldchange) for reaction abundance calculated via summed NSAF. (b) –log10(p-values) versus log2(fold-change) for
reaction abundance calculated via relative number of proteins.
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4.3.5 Pathway reconstruction reveals differences between NEC and non-NEC
To explore the relationship between reactions significantly different between NEC or
non-NEC using either PN or NSAF, a reaction-to-compound network was created for each of the
two metrics (Figure 4.7 and Figure 4.8). These two networks revealed several significant host,
shared, and microbial reactions connected by similar compounds that either indicated a pathway,
multiple reactions acting on the same compound independent of a pathway, or singleton
reactions with no other connected reactions. The networks tended to follow the trends observed
in Figure 4.6, with the NSAFk network reflecting more host reactions and reactions that were up
among healthy infants, while the PN network reflected more microbial reactions that also had
more relative proteins in NEC rather than non-NEC infants. Upon manual inspection, several
reaction groupings of interest were uncovered.
In the network indicative of reactions significantly different between NEC and non-NEC
by NSAFk, host reactions associated with the biosynthesis of mucin and bile acids were more
abundant in healthy infants than those that developed NEC. Several groupings of reactions were

Figure 4.7: Reaction to compound network made up of all the rzeactions that are significantly different between
NEC and non-NEC using summed NSAF abundance. Green nodes are up in infants that do not develop NEC and
orange nodes are up in infants that develop NEC. Square blue nodes are compounds, circle nodes are microbial
reactions, diamond nodes are shared reactions, and triangle nodes are host reactions.
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shared or a mix of host, shared, and microbial reactions. Among these, deoxyhypusine synthase,
acetate metabolism, and retinol metabolism appeared to be up in infants that did not develop
NEC, while formate appeared to be up in infants that developed NEC. Further inspection of
deoxyhypusine synthase, however, revealed that this trend was driven by host proteins as the
shared aspect was driven by proteins unknown origin in baby 70, one of the healthy infants.
Among exclusively microbial reactions, nitric oxide synthase, folate biosynthesis, and antibiotic
resistance appeared to be up in healthy infants. In contrast, arginine degradation and the
biosynthesis of siderophores enterochelin and aerobactin were found to be more abundant in
infants that developed NEC.
In the PN, microbial reactions involved with the biosynthesis of siderophores were also
observed; however, in this case, all the reactions between chorismate and enterochelin were
found to have more relative proteins in NEC than in non-NEC babies indicating a strong
siderophore signal, and the value of using multiple methods for functional quantification. Apart
from the siderophore biosynthesis, microbial reactions associated with the catabolism of amino
acids and lipoyl synthase were found to have more relative protein in NEC than non-NEC.
Quinone oxidoreductase was found to have more relative microbial proteins in infants that did
not develop NEC. Reactions associated with the enzyme lactosylceramide alpha-2,3sialyltransferase, which converts lactosyl ceramides to glucosylceramides or extends

Figure 4.8: Compound to reaction network of reactions that are significantly different in abundance using relative
numbers of proteins. Green nodes are up in infants that do not develop NEC and orange nodes are up in infants that
develop NEC. Square blue nodes are compounds, circle nodes are microbial reactions, diamond nodes are shared
reactions, and triangle nodes are host reactions. In addition, pathway from chorismate to enterochelin, a sideraphore,
is depicted.
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glucosylceramides, had more relative host proteins in infants that developed NEC than those that
did not.

4.4 Discussion
Previous studies have shown that, though highly variable in composition, gut
microbiomes are much more conserved in function using either broad functional categories,
metabolic modules, or orthologous groupings (The Human Microbiome Project 2012, BlakeleyRuiz et al. 2019). This study takes these findings one step further, demonstrating that the most
specific entities of metabolic functions, the reactions themselves, are more likely to be shared
between samples in preterm infants than orthologous groupings. This indicates that specific
function rather than protein sequences may be a more stable space for analysis of microbiome
functions than orthology or individual proteins in highly variable microbiomes.
Linked together by the compounds that they catalyze, these reactions were used to
reconstruct metabolic networks. Though metaproteomes have previously been used to
reconstruct metabolic networks and even model metabolism (Tobalina et al. 2015), this study
revealed that these reaction networks could be used to consistently build sample-specific
metabolic networks dominated by a single connected component even after the removal of
currency metabolites like ATP. Although a flux balance analysis was beyond the scope of this
study (Orth et al. 2010), this study showed that reasonably deep metaproteomes are a powerful
tool for guiding comprehensive metabolic modeling of microbial systems.
A previous study successfully reconstructed 773 genome-scale metabolic models of
bacteria derived from human gut microbiomes (Magnúsdóttir et al. 2017). After comparing these
models to the human genome, it was found that approximately 8% of metabolic reactions were
shared between the host and the reconstructed microbial models. Due to the relatively high
percentage of human proteins in preterm infants relative to adults, the metaproteomes in this
study yielded fairly deep human and microbiome proteomes allowing for the concurrent analysis
of reactions of microbial, host, or shared origin. In this study, approximately 36% of the total
reactions detected were shared between the host and the microbiome, while only 13% were
unique to the host showing that even in less complex microbial communities in the gut, the
microbiome contributes the greater share of metabolic functional capacity. Within any given
sample, these percentages shifted towards more microbial reactions at the expense of host
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reactions over time. This was further reflected in an increase in microbial edges over time
relative to host edges. Though NEC infants showed an opposite trend, this was primarily driven
by the single infant whose sampling extended beyond day 80 after birth.
Division of detected reactions into host, shared, and microbial groupings allowed for the
concurrent analysis of host and microbial functions associated with the development of NEC or
the absence of NEC. This analysis was conducted by two metrics: normalized summed NSAF
abundance, NSAFk, and the relative number of proteins, PN, and these metrics offered
complimentary information. Reactions uncovered by these two metrics provided a variety of
insights into gut functionality in necrotizing enterocolitis. Among microbial reactions that were
less abundant in NEC were reactions involved in nitric oxide synthase, folate biosynthesis, and
quinone oxidoreductase. Nitric oxide is involved in healthy construction of the mucosal layer
(Brown et al. 1993), suppression of inflammation, protection against gastric damage (Calatayud
et al. 1999), and previously shown to be correlated with healthy tissues in Necrotizing
enterocolitis (Nowicki et al. 2006, Lanas 2008). Folates are critical co-factors for the
biosynthesis of a variety of molecules in the host (Rossi et al. 2011). A major source of folates
are bacteria in the gut microbiome (Engevik et al. 2019), and its deficiency has been associated
with microbiome dysbiosis (Pan et al. 2017). A probiotic with a quinone oxidoreductase has been
shown to recover the microbiome from dysbiosis (Pan et al. 2019).
In the case of microbial reactions that were up in NEC, several reactions associated with
the degradation of amino acids were observed, and infants with NEC have been shown to have
lower amino acid serum concentrations (Becker et al. 2000). The most interesting microbiome
signal that was up in NEC was the biosynthesis of siderophores. Siderophores are iron-chelating
molecules that assist microbes in iron harvesting (Wandersman and Delepelaire 2004). Brown et
al. 2018 previously detected iron harvesting proteins as up in NEC as well (Brown et al. 2018);
however, in the current study, the entire pathway from chorismate to enterochelin was visible as
up in NEC, suggesting multiple organisms taking up this function in the lead up to necrotizing
enterocolitis. Infants with NEC have been shown to have a predisposition for being unable to
uptake iron as efficiently as infants that do not develop NEC (Göpel et al. 2018). Iron
homeostasis dysregulation is closely associated with inflammation, and this has been shown to
lead to a higher fecal iron load when colitis is induced in mice (Semrin et al. 2006, WesslingResnick 2010, Verma and Cherayil 2017, Mahalhal et al. 2018). Increased iron harvesting is
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closely associated with pathogen virulence and has been suggested as a potential target to combat
infections (Page 2019). Treatment with lactoferrin, an iron-binding protein, has also been shown
to ameliorate NEC (Raghuveer et al. 2002, Telang 2018). Interestingly chorismate is a major
source of folate in the gut, suggesting reduced folate biosynthesis may be a result of chorismate
being repurposed towards siderophore production (Engevik et al. 2019). Together these results
indicate disruption iron homeostasis may be involved in triggering microbial virulence leading to
NEC.
On the host side, the mucosal layer forms an important protective layer preventing the
microbial invasion of the host; however, in this study reactions associated with biosynthesis of
mucin were down in NEC suggesting a disruption in production of mucin in infants that develop
NEC, which could offer a host explanation for the disruption of the mucosal layer in NEC
(Hodzic et al. 2017). Less clear cut, high bile acid load is associated with NEC (Halpern and
Dvorak 2008, Hulzebos et al. 2017), but the results in this study indicate that bile acid production
is down in NEC. One explanation could be that since infants that develop NEC are predisposed
to iron uptake deficiency, possibly NEC infants are also not as effective as taking up bile-acids
leading to bile-acid accumulation and a decrease in bile acid production. A further study showed
higher variance in bile-acids available, suggesting a disruption of bile acid homeostasis rather
than a general increase (Knapp et al. 2020).
Together these results present a picture of the crosstalk between the host and microbiome
in the formation of NEC. In the lead up to the development of NEC, the host is predisposed to
not uptake iron and bile acids. This leads to disruption of bile-acid and iron homeostasis, which
disrupts folate biosynthesis and mucosal layer maintenance. This opens the door for invasion by
pathogenic iron harvesting bacteria. These results, however, have some limitations. The
identified reactions are putative annotations created by orthology based functional transfer. Each
protein could point to many reactions leading to some overlap in quantification that may be
indicative of more than one reaction. The experimental setup with only six NEC infants and nonconsistent time-point sampling makes the results predictive, but not confirmatory. Nevertheless,
this study presents a strong case for the use of reactions when comparing metaproteomes
between conditions when exploring host and microbiome functions concurrently. Since adult
metaproteomes contain substantially less host protein relative to microbial protein, this analysis
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presents an argument for concurrent proteome measurement of colon tissue and fecal material to
create a comparable host/microbiome functional repertoire.
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5.1 Introduction
Gut microbiome disruption correlates with altered metabolism (Donohoe et al. 2011),
chronic pain (Rajilić–Stojanović et al. 2011), and increased inflammation (Lloyd-Price et al.
2019). Obesity also correlates with increased inflammatory cytokines (Poret et al. 2018, Elisia et
al. 2020) and chronic pain (Hitt et al. 2007), while disrupting the gut microbiome (Ridaura et al.
2013). Obesity triggered disruption of the microbiome manifests as a decrease in the overall
richness/diversity of the gut microbiome and a decrease in the abundance of Bacteroidetes
bacteria relative to Firmicutes bacteria (Ley et al. 2005, Turnbaugh et al. 2009, Le Chatelier et al.
2013); however, some of these findings have proven difficult to reproduce in meta-analyses
using body-mass-index (BMI) as the delimiter between lean and obese (Finucane et al. 2014,
Walters et al. 2014, Sze and Schloss 2016). Obesity, however, is not one type of disease, and
general metrics for obesity like BMI do not capture the individual nuances of different types of
obesity, such as genetic versus diet-induced obesity. Different kinds of obesity affect the
microbiome distinctly both in the magnitude of the effect and in the specific taxonomical
changes in composition. This could explain some of these inconsistencies as genetic obesity
appears to increase the weight of mice more rapidly than high-fat diet, while high-fat-diet
induced obesity appears to have a greater magnitude impact on the microbiome (Carmody et al.
2015, Pfalzer et al. 2015).
Opioids are a standard treatment for chronic pain, yet opioids also have a significant
effect on the gut microbiome and specific inflammatory cytokine markers. Specifically,
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morphine has been shown to increase the abundance of Enterococcus bacteria and the cytokine
IL-6, while suppressing the abundance of Lachnospiracea bacteria (Banerjee et al. 2016, Acharya
et al. 2017, Wang et al. 2018). The above information indicates a relationship between obesity
and opioid use through their correlations with microbiome disruption, chronic pain, and
inflammation; however, to the authors’ knowledge, no study has looked at the effects of
morphine on the microbiome in the context of obesity and no study has looked at the effects of
morphine on microbiome function.
Given the coexisting epidemics of obesity and opioid abuse, it is of paramount
importance to seek a better understanding of the mechanisms by which obesity and opioids
interact to promote inflammation and alter gut microbiomes composition and function (Figure
5.1). Using a combined metagenomics and metaproteomics experimental design, the present
study sought to determine the impact of chronic morphine administration on the gut microbiome
composition and function in mice with genetically endowed versus diet-induced obesity.

5.2 Methods
5.2.1 Study Design and Sample Collection
Adult male db/db (Stock# 000697; n=6), wild-type B6 (Stock# 000664; n=6), and B6
mice with diet induced obesity (DIO) (Stock No: 380050; n=6) were purchased from The
Jackson Laboratory (Bar Harbor, ME). The mouse feed was purchased from Research Diets,
Inc., (New Brunswick, NJ, USA). The B6 and db/db mice were fed normal Teklad 8640 rodent
chow containing 5% fat (Envigo, Madison, WI), the DIO mice were fed a 60% fat diet (Research
Diets catalog number D12492). Environmental housing conditions for all mice included a 12:12
light:dark cycle, maintenance of thermo-neutral room temperature, and free access to food and
water.
After a post-shipment acclimation period, mice were weighed, anesthetized with
isoflurane, and implanted with Alzet osmotic pumps delivering 10 mg/kg/day of morphine
sulfate, at a rate of 0.5 uL/h, or saline (vehicle control) and then maintained for two weeks. All
mice were weighed daily and individually housed for 24 hours in metabolic cages to collect feces
and urine. The urine samples were used to confirm morphine metabolism. Finally, all mice were
anesthetized with isoflurane and terminal samples (blood plasma, colon tissue, and colon fecal)
material were surgically taken from all 18 mice at the end of the study. Terminal blood was
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collected from right ventricle in EDTA-treated collection tubes then centrifuged at 3000 rpm.
Plasma was transferred to clean tubes and frozen at -80oC. Colon tissue was resected, fecal
material evacuated, then both sample types were frozen immediately upon transfer to clean tubes
and stored at -80oC.
5.2.2 Protein Extraction
Feces extracted by metabolic cage or directly from the colon were treated identically.
Between 8-50 mg of fecal material were placed in an eppendorf tube. Approximately 200 ųL of
0.115 mm zirconium oxide beads were added to each tube, followed by 350-400 ųL of lysis
buffer (2% SDS in 100mM Tris-HCL buffer) in each tube. Samples were lysed by bead beating
in a Next Advance bead beater at speed 10 for 5 minutes. Samples were centrifuged at 21,000 g
for 10 minutes. Next, 200 ųL of supernatant was pipetted for protein extraction, and the
remainder (with beads) were used for DNA extraction. Protein extraction supernatant was heated
at 85°C for 10 minutes, incubated with 25mM DTT for 20 minutes, and then incubated with 75
mM IAA for 20 minutes. Protein was then extracted using a chloroform methanol extraction
protocol: addition of 800 ųL of methanol, 200 ųL of chloroform, and 600 ųL of water followed
by 10 minutes of centrifugation at 21,000 g. Supernatant was disposed of and remaining pellet
was washed using methanol. Dried pellet was reconstituted in sodium deoxycholate (SDC)
solution made up of 4% SDC in 100 mM ammonium bicarbonate. Protein concentration was
measured using bicinchoninic acid (BCA) assay. Each sample was adjusted to be 250 ųg of total
protein in 500 ųL solution. Peptides were digested twice using a 1:75 (wt/wt) trypsin ratio, once
for three hours and once overnight. After digested, solution was filtered to remove undigested
peptides. Digestion reaction was quenched using 1% formic acid to lower pH, then solution was
cleared with an ethyl acetate wash. Peptide concentration was determined via BCA assay.
Peptides were then lyophilized/dried via SpeedVac and reconstituted in Solution A (95% LCMS-grade H2O, 5% LC-MS-grade acetonitrile, 0.1% formic acid) at a concentration of 1 ųg/ųL.
5.2.3 DNA Extraction
DNA extraction was performed using a Quick-DNA Fecal/Soil Microbe kit (Zymo
Research, Irvine CA), according to manufacturer’s protocol. The extracted DNA was further
purified using the DNA Clean & Concentrator kit (Zymo Research) and quantified by
fluorometry using a Qubit assay (ThermoFisher Scientific).
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5.2.4 16S rRNA Amplicon Sequencing and Analysis
For 16S rRNA amplicon sequencing, the V4 hypervariable region of the 16S rRNA gene
was amplified using universal primers derived from the original 515F and 806R primers (5′
GTGCCAGCMGCCGCGGTAA and 5’ GGACTACHVGGGTWTCTAA, respectively) (Bates
et al. 2011) fused to Illumina sequencing adapters, following the procedure developed by
(Lundberg et al. 2013). We also supplemented the reaction with a 5% of a modified 515F primer
that increases the coverage of TM7/Saccharibacteria (5′ GTGCCAGCMGCCGCGGTCA)
(Liang et al. 2018). 12-nucleotide barcode sequences were incorporated into the second stage
amplification reaction to enable sample multiplexing. The final amplicons were pooled, purified
using Agencourt Ampure XP beads and quantified by Qubit. A pooled amplicon sample was
sequenced (2 x 250 nt) on an Illumina MiSeq instrument (Illumina Inc, San Diego, CA) using a
v2 500 cycle kit.
Raw sequence reads were trimmed of the PCR primers/adaptors using cutadapt
(https://doi.org/10.14806/ej.17.1.200) and joined using the Qiime script join_paired_ends.py.
Joined reads were processed using the qiime2 (v. 2019.1.0) framework (Bolyen et al. 2019).
Reads were demultiplexed using the demux plug-in and denoised using the dada2 plug-in
creating non-redundant amplicon sequence variants with a table of read counts per sample
(Callahan et al. 2016). A phylogenetic tree was created using the raxml-rapid-bootstrap plug-in
with default settings (Stamatakis 2014). Based on the data summary, diversity metrics Shannon
(alpha-diversity), Simpson (alpha- diversity), Faith (phylogenetic alpha-diversity), weighted and
unweighted UniFrac (phylogenetic beta-diversity), Bray-Curtis (beta-diversity considering
abundance and presence versus absence), and Jaccard (beta-diversity considering just presence
and absence) were calculated with the diversity plugin using a rarefaction of 50,000 reads (Faith
1992, Lozupone et al. 2007). Taxonomy was assigned to amplicon sequence variants using the
qiime 2 Silva database classifier (Pruesse et al. 2007, Bokulich et al. 2018). Amplicon sequence
variants were filtered if they had less than 50 reads across all samples, and these robust amplicon
sequence variants were used in subsequent statistical analysis using the gneiss plug-in, and
MicrobiomeAnalyst, https://www.microbiomeanalyst.ca/ (Dhariwal et al. 2017, Morton et al.
2017). In MicrobiomeAnalyst, a random forest classifier was used to determine bacterial families
most associated with each experimental group, and gneiss generated a heatmap of the overall
16S data.
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5.2.5 Whole Genome Metagenomic Sequencing and Analysis
Metagenomic sequencing was performed at the Sequencing Center of HudsonAlpha
Institute (Huntsville, AL). Genomic DNA from 18 colon fecal samples was sheared and used to
generate libraries that were sequenced (2 x 150 nt) on an Illumina NovaSeq instrument. The raw
reads quality checked and trimmed using Trim Galore
https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/. Reads were then assembled
with an aim to extract metagenome assembled genomes using a modified version of the Olm et
al. procedure (Olm et al. 2017). In brief, all 18 samples where co-assembled using Megahit with
the parameters k-min set to 31 and k-step set to 10 (Li et al. 2015). Mouse and human DNA was
removed using bbsplit against a masked human and mouse databases with the parameter minid
set to 0.95 similar to as described here, http://seqanswers.com/forums/showthread.php?t=42552.
Cleaned sequence reads were single sample assembled using idba_ud with default parameters
(Peng et al. 2012). Reads from all samples were mapped to all assemblies using bwa mem piped
to samtools creating sorted bam files (Li and Durbin 2009, Li et al. 2009). Subsequent bam files
were used to bin contigs from all assemblies by coverage and tetranucleotide frequency using
Metabat2 (Kang et al. 2019). Genomes were quality checked using checkM (Parks et al. 2015).
Taxonomy was assigned to all genomes that passed the threshold >50% complete <25%
contaminated using gtdb-tk, which uses pplacer and ANI to classify genomes based on a
database of over 150,000 genomes from NCBI and other sources (Parks et al. 2018, Chaumeil et
al. 2019). Over 54% of genomes were >50% complete, and <10% contaminated out of the box,
minimum standard for a medium quality genome so no further curation was done (Bowers et al.
2017). Select genomes that were >50% complete >10% contaminated were refined using Anvi’o
by tetranucleotide frequency clustering (Eren et al. 2015). Finally, all medium quality genomes,
>50% complete and <10% contaminated were dereplicated using dRep at 99.5% ANI and 95%
ANI to create non-redundant genome and species clusters respectively (Olm et al. 2017). For
each group, the best quality non-redundant genome was selected as a representative genome.
Raw data and representative genomes are available in BioProject PRJNA603829. Protein
sequences from the assemblies were extracted from the checkM result and annotated using
emapper from the eggNOG database (Huerta-Cepas et al. 2017, Huerta-Cepas et al. 2018).
Abundance of each representative genome was calculated using the inner-quantile mean
coverage (Q2Q3 mean coverage) of each genome as calculated by Anvi’o.
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5.2.6 Metaproteomic Measurement
Colon extracted fecal samples were measured on a Q-Exactive Plus (Thermo Fisher
Scientific, Bremen, Germany) using an auto-sampled online two-dimensional chromatography
system coupled to an electrospray emitter. Briefly, a three-phase back column was created using
150 um ID polyimide-coated fused silica containing 5cm of Aqua C18, 10cm of Luna strong
cation exchange (SCX), and 5cm of Aqua C18 (Phenomenex, Torrance, CA). This frit was then
connected to a 30cm C18 analytical column with an electrospray emitter at the end. A 12ųg of
peptide solution, per sample from the previously detailed extraction method was loaded onto the
back-column via an UltiMate 3000 HPLC auto sampler over a 30 minute load step, then 4
subsequent salt pulse steps of 35, 50, 100, 500 nano molar ammonium acetate were used to push
peptides onto the analytical column. Peptides were then separated over a 150-minute reverse
phase gradient, while being sprayed onto the mass spectrometer. A final 500 nano molar
ammonium acetate salt pulse was used as a wash step prior to the load of the next sample.
Peptides were detected using data dependent acquisition, with 5 peptides isolated for MS2
fragmentation per MS1. Peptides were fragmented using HCD fragmentation, and previously
detected mass-to-charge ratios, where placed on a 30 second exclusion list.
5.2.7 Protein identification
All prodigal gene calls extracted by running checkM on the medium quality
representative genomes were extracted to create a protein database for proteomic analysis. The
UniProt mouse proteome was added to this protein database, and all sequences were clustered at
98% identity using cd-hit to remove redundancy (Fu et al. 2012). After, a list of common protein
contaminants was added to the protein database. Protein identifications were conducted using the
crux (v. 3.2.8aa66a2) framework (McIlwain et al. 2014). Initially an index of the protein
database was created using tide-index with the settings: --missed-cleavages 2 --mods-spec
C+57.02146,2M+15.9949 --clip-nterm-methionine T --decoy-format protein-reverse. Then an
initial search was conducted using tide-search with a precursor window of 10 ppm. After this
search using an in-house python script, a new protein database was created for each sample
based on all proteins that were potentially matched to a spectrum. With these protein databases,
each sample was searched against a sample specific database using tide-search with the
following parameters: --compute-sp T --exact-p-value T --score-function both --precursor84

window 10 --precursor-window-type ppm --num-threads 10 --mz-bin-width 1.0005079 (Diament
and Noble 2011, Howbert and Noble 2014). Final search results were all submitted together to
percolator for false discovery rate (FDR) calculation (Käll et al. 2007). For a protein to be
identified, it needed to have at least one unique peptide identified with a peptide spectral match
FDR of less than 1%. Protein FDR was also calculated, but not used in initial filtering. Retention
time was extracted for all peptide spectral matches using an in-house script, and MS1 apex
feature intensity was calculated for each peptide spectral match with a q-value < 0.01 using
moFF (Argentini et al. 2016). The moFF match between runs feature was specifically not used
due to issues with false hits. Protein abundance for each sample was calculated by summing
intensities for all unique MS1 features. Then all quantified proteins with a unique peptide were
loaded onto a matrix. This matrix was log2 transformed, loess normalized, and mean centered
using Inferno (Polpitiya et al. 2008). Proteins were also similarly quantified by spectral counting
when appropriate.
5.2.8 Richness and principle component comparison between conditions and omics methods
Frequency of robust ASV’s from qiime 2, inner-quantile of mean coverage of
representative genomes from Anvi’o, summed spectral count from genome specific proteins, and
individual protein intensity were all independently submitted to log transformation, loess
normalization, and mean centering in Inferno (Polpitiya et al. 2008). Subsequently missing
values were imputed as zero, and principle components were calculated using base R. Finally,
PCA plots were rendered using ggplot2’s scatter plot feature. To determine richness of each
measurement. Number of quantified filtered ASV’s in each sample, Genomes with an innerquantile mean coverage >2, and number of proteins were counted per sample. Significant
difference between conditions was calculated using Base R aov and TukeyHSD functions, and
boxplots were rendered using ggplot2.
5.2.9 Evaluating newness of representative genome’s gene calls
The newness of protein sequences taken from representative genomes was evaluated
against a previously compiled mouse microbiome gene catalog (7/17/2015), nr (10/16/2019),
environmental nr (9/28/2019), and UniParc (9/19/2019). All these databases were downloaded
on October 16, 2019 (Xiao et al. 2015, The UniProt 2018). A diamond blastp was then conducted
between the protein database used for metaproteomic analysis and these four databases
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(Buchfink et al. 2015). Proteins that were not matched were recorded, and the top percent
identity for each matched protein was also recorded.
5.2.10 Differential protein analysis
Normalized proteins intensities were filtered down to proteins that were quantified at
least 3 times in a condition. These proteins were then submitted to serial T-tests between B6
control, and an experimental condition (B6 T, db/db S, db/db T, DIO S, DIO T). Using python, tstatistic, confidence interval, p-value, and Benjamini-Hochberg procedure was calculated for
each comparison (Benjamini and Hochberg 1995). Proteins that passed an Q of 0.1 were
considered to be significantly different between two conditions. Prior to t-test calculation,
missing values were imputed with a random number down shifted 2.8 standard deviations from
the mean and within half a standard deviation. The goal was to avoid comparisons between zero
and a large number, while ensuring that any situation where a protein was quantified in all
samples in one condition and none in the other the protein would be significant. All proteins in
this set had a protein FDR below 5%.
Hypergeometric tests were used to determine if any species were significantly enriched
on one side of the comparison or the other. Among these species that had a q < 0.01 species that
had greater than 15 significant proteins in one condition were isolated for future analysis. These
species were also compared by number of proteins in a condition versus the inner quantile mean
coverage of a representative genome of that species in the same conditions.
5.2.11 Functional analysis
COG broad functional categories and KEGG Orthologs were extracted for each protein
from the emapper results (Tatusov et al. 2000, Kanehisa et al. 2016). The KEGG ftp was used to
connect KEGG orthologs to pathways, module, reactions, and Brite hierarchies. For each
grouping the number of quantified proteins per sample was counted. For Broad COG categories
number of proteins was divided by number of proteins to create a percentage, and statistical
analysis was conducted by Two-way ANOVA and TukeyHSD in base R. For Pathways,
Modules, and Brite hierarchies all groupings were counted in one matrix, and the count data was
transformed and normalized by centered log ratio after filtering any category that did not have
more than 4 proteins in at least one sample. The same was done for KO terms, but once for all
KO terms with at least 4 proteins in a condition, and again for all KO terms with at least 7
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proteins in a condition. The second filtering was done to help elevate more abundant KO terms.
All of these results were statistically analyzed by Two-Way ANOVA in Perseus (Tyanova et al.
2016), and confirmed by Two-Way ANOVA and TukeyHSD in R. P-values within each analysis
were stacked and FDR was controlled by Benjamini-Hochberg procedure (Q < 0.25).
5.2.12 Cytokine Assays and Analysis
Plasma samples collected as previously described and colon tissue (cryo grinded then
protein extracted as previously described) homogenates were analyzed for inflammatory factors
using Milliplex MAP Mouse Cytokine/Chemokine Magnetic Bead Panel (Millipore Sigma,
Burlington, MA) premixed 32-plex kit according to the protocol. All samples were 0.2 um
filtered, and plasma volume was doubled (25 uL) to achieve detectable levels for most cytokines.
Tissue supernatant volumes were based on protein concentration by NanoDrop readings of
individual samples to achieve 15 ug total protein per well. Assay samples were aliquoted in
triplicate; after protocol completion, plates were read on a Luminex analyzer.
Absolute quantitation in pg/mL for each cytokine (limit of detection 3.2 pg/mL) was
achieved using Luminex software provided polynomial standard curves. Values below 3.2
pg/mL were imputed with a random number between 0 and 3.2 pg/mL. Exploratory data analysis
using PLS-DA in the MixOmics R package was used to hypothesize which cytokines were
significantly more abundant in each line, and in morphine treatment (Rohart et al. 2017). Twoway ANOVA followed by Tukey Honest Significant Difference (HSD) was used to confirm
hypotheses.
5.2.13 Urinary Metabolites
Mouse urine collected during 24-hour metabolic cage duration was analyzed by LCMS/MS on a Shimadzu LCMS-8040 in multiple reaction monitoring (MRM) mode for the
following analyte transitions (m/z): morphine (285.70 > 201.00, 285.70 > 152.35), morphine-3𝛽-D-glucuronide (462.20 > 286.15, 462.20 > 183.15, 462.20 > 58.20), hydromorphone (285.75 >
184.95, 285.75 > 157.00), hydromorphone-3-𝛽-D-glucuronide (462.20 > 286.10, 462.20 >
184.95), and normorphine (272.20 > 152.00, 272.20 > 165.00, 272.20 > 121.00). Spiked internal
standards morphine-D6 (292.00 > 201.05, 292.00 > 152.95, 292.00 > 165.00) and morphine-3-𝛽D-glucuronide-D6 (465.25 > 289.10, 465.25 > 201.10, 465.25 > 183.00) added to each sample at
the same concentration for standardization and normalization. All standards obtained from
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Cerilliant (Round Rock, TX) were compiled into a stock solution used for serial dilution into
aqueous urine matrix to achieve a nine-level calibration range: 10 to 5,000 ng/mL for morphine,
hydromorphone, and normorphine; 50 to 25,000 ng/mL for morphine-3-𝛽-D-glucuronide and
hydromorphone-3-𝛽-D-glucuronide. Urinary drug testing analysis confirmed morphine dosing of
experimental treatment subjects in addition to hepatic drug metabolism among all three mouse
lines.

5.3 Results
To compare microbiome changes due to morphine in the context of different kinds of
obesity, three lines of mice from the same genetic background were selected. The control group
comprised C57BL/6J mice (B6; n=6) consuming a standard mouse diet. The two groups of obese
mice included C57BL/6J with diet induced obesity (DIO; n=6) caused by consuming a 60% fat
diet, and B6.BKS(D)-LepRdb/J (db/db; n=6) consuming a standard mouse diet (Figure 5.1). The
db/db mice have a mutated gene that codes for the leptin receptor, which confers susceptibility to
obesity and type-2 diabetes (Coleman 1978). Three mice from each of the three lines were
treated either with a saline vehicle control, or morphine administered continuously for two weeks
via chronically implanted Alzet pumps. At the end of the treatment, feces were collected from
the metabolic cages (24 hours) and surgically excised from the colon. The three mouse lines had
significantly different weights, with db/db mice heavier than DIO and DIO heavier than B6 mice
(Figure 5.1). To evaluate morphine metabolism, urine was collected in the metabolic cages and
measured with a targeted mass spectrometry assay. Morphine metabolites were detected only in
mice treated with morphine, although the db/db mouse had significantly lower levels for these
metabolites. (Figure 5.1).
To show that inflammatory effects of morphine and obesity were observable in this study,
plasma (systemic) and protein from colon tissue (localized) were analyzed with a panel of mouse
chemokines and cytokines (Figure 5.2). Most analytes were not detectable; however, markers of
inflammation were observed to be elevated in db/db, DIO, or morphine treated mice. Each group
had different elevated analytes, and morphine’s inflammatory effect could only be observed in
the lean mice (Figure 5.2). There were some conflicting results for example the mouse homolog
of IL-8, KC, was more abundant in db/db plasma; however, the anti-inflammatory cytokine IL10 was more abundant in db/db colon tissue. This could be caused by the colon tissue attempting
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Figure 5.1: Experimental design for mouse study. (A) Flow chart of starting hypotheses of bidirectional interaction
between pain, obesity, inflammation, opioid use and the gut microbiome. (B) Side by side comparison of db mice vs
B6 Mice. (C) Table describing experimental setup. (D) Boxplot showing weight in grams of mice. P-Values
calculated by TukeyHSD in R. (E) Boxplot depicting morphine quantities in mouse urine Analyzed by triple
quadrupole mass spectrometer. Images are from the Jackson Laboratory website.
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Figure 5.2: Cytokine analysis reveals different markers of inflammation for different types of obesity and morpine.
(A-C) Boxplots comparing abundance of TNF-a, KC, and MIG in plasma across different mouse lines. (D-F)
Boxplots comparing abundance of Eotaxin, IL-10, and MIP.1b in colon tissue across different mouse models. PValues calculated by two-factor ANOVA (Model versus Treatment) followed by Tukey HSD. (G) Boxplot
comparing abundance of IL-6 in plasma between B6 model morphine samples to B6 model saline samples. (H)
Boxplot comparing abundance of MCP.1 in colon tissue samples between B6 model morphine samples versus B6
model saline samples. P-values calculated by welch t-test.

to compensate for the systemic inflammatory state in the db/db mice. While pro-inflammatory
IL-6 was seen to be elevated in morphine treated B6 mice; pro-inflammatory MCP.1 was seen to
be elevated in colon tissue of saline treated B6 mice relative to morphine treated B6 mice.
Eotaxin a chemokine associated with the development of the mucosal layer was elevated in B6
mouse tissue relative to db/db and DIO tissue potentially eluding to the microbiome disruption
caused by the two types of obesity (Loktionov 2019). These results show clear but distinctly
driven systemic inflammation due to DIO, db/db, and morphine, with some conflicting results at
the localized level.
5.3.1 Comprehensive microbiome characterization reveals a mouse gut microbiome
membership that is underrepresented in public repositories
To provide an overview of the mouse gut microbiome’s composition and guide
subsequent whole genome metagenomic sequencing, 16S rRNA amplicons derived from
metabolic cage and colon fecal samples were sequenced to saturation revealing 157- 467
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amplicon sequence variants (ASV’s) per sample and 1,546 in total. While previous reports
indicated that collection over 24 hours should not have a major impact on the composition of the
microbiome (Lauber et al. 2010, Song et al. 2016), the anerobic nature of the gut microbiome
provided concern that this would have an undue effect on some of the more detailed results.
Results from the two samples types aligned with the literature in principle. Sample types were
overall indistinguishable by beta-diversity analysis; however, 350 out of 1,546 amplicon
sequence variants (ASV’s) detected in total were not detected in the colon fecal samples,
differences between morphine and saline were more observable in the colon fecal samples, and
alpha diversity results conflicted between the two sample types (Figure 5.3). Thus, subsequent
analysis was done using the colon fecal samples as the best representative of the native
microbiome.
Matching ASV’s to the Silva the database revealed that 95% of the ASV’s could not be
classified at the species level. Many sequences matched with less than 95% nucleotide identity
when compared to the NCIB 16S rRNA database (Figure 5.4) (Pruesse et al. 2007, Bolyen et al.
2019). This implies that many of the bacteria present in these samples remain uncultured and do

Figure 5.3: Alpha diversity metrics for samples collected directly from colon versus in a metabolic cage.
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not have a representative in the NCBI database reinforcing the need for obtaining protein
sequences using metagenomics.
Metagenomic sequencing of each colon extracted microbiome sample resulted in an
minimum 250 million reads per sample (2 X 150 bp). Sequence binning and curation extracted
590 medium-quality metagenome-assembled genomes (MAGs), as determined by previously
defined standards (Bowers et al. 2017). Between 215-467 of the genomes were quantifiable per
sample suggesting a thorough extraction of MAGs from the metagenome based on the 16S
results (Figure 5.4). The MAGs represent 460 distinct species with a 95% ANI threshold (Olm et
al. 2020). Only 7% of the genomes are represented in the Genome Taxonomy Database, which is
compiled from RefSeq and GenBank (Parks et al. 2018, Chaumeil et al. 2019) (Figure 5.4). As
the number of named species assembled was even lower, this indicates that the mouse
microbiome is still underrepresented in sequence databases. Supporting this, blast searches of all
MAG derived protein sequences against the UniParc, NR databases, and mouse catalog yielded
mean top-blast alignments <90 percent amino acid identity (Figure 5.4) (Xiao et al. 2015,
Coordinators 2018, The UniProt 2018).
Predicted encoded proteins from the MAGs were used as the reference database for
metaproteomic identifications. In total, 1,212,277 non-redundant protein sequences clustered at
98% identity were derived from the metagenome assembled genomes and combined with host
proteins to generate a protein sequence database for searching against spectra. 97% of these nonredundant proteins were resolvable down to the species level making species-resolved
metaproteomics on previously uncharacterized species possible. Using a 2D-LC-MS/MS
method, 115,628 proteins were detected with at least one unique peptide, with 11,112-16,238
non-redundant proteins detected in each sample (peptide spectral match q < 0.01) (Figure 5.4).
Less than 10% of the proteins detected in each sample belonged to the host, the remainder were
bacterial. Approximately 70% of these proteins were assigned a functional annotation using the
eggNOG database, enabling subsequent comparative metabolic inferences across the mice and
treatments.
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Figure 5.4: Comprehensive profiling of the mouse gut microbiome reveals a microbiome underrepresented in public
repositories. (A-C) Boxplots depicting the number of ASV’s, quantifiable genomes, and proteins detected in each
sample respectively. (D) pie chart depicting the percentage of ASV’s classified using the Silva database down to the
species level, unclassified at the species level, and then unclassified at the genera level. (E) pie chart depicting the
percentage of genomes classified down to the species, genus, family, class, or order level. All genomes were
classified at the phylum level. (F) boxplot depicting amino acid percent identify match of each protein to
environmental NR, mouse catalog, NR, and UniParc databases. (G) boxplot of nucleotide percent identity match of
each ASV to the NCBI 16S rRNA database.
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5.3.2 Morphine alters the gut microbiome composition but is eclipsed by obesity effects
To see if morphine or different kinds of obesity had any effects on the diversity of gut
microbial communities, 16S data was evaluated using varying alpha diversity metrics. Except for
the Faith phylogenetic diversity of amplicon sequence variants taken from the metabolic cage
samples, no metric of alpha diversity indicated any differences in within sample diversity
between conditions (Figure 3.3). The total number of amplicon sequence variants, genomes, and
protein detected in each sample was significantly lower in DIO suggesting lower community
richness due to high-fat-diet in agreement with a recent meta-analysis (Figure 3.4) (Bisanz et al.
2019). Given that db/db mice have a significantly greater weight than DIO mice (Figure 3.1), this
implies that the source of obesity drives decreases in microbial population richness not obesity
itself. Morphine did not appear to have any effect on alpha-diversity or richness of the gut
microbiome.
To evaluate changes in microbial composition between conditions, mean-centered log
transformations of ASV abundance and genome abundance calculated by metagenomic coverage
or metaproteomic spectral counts were evaluated by principle component analysis (Figure 5.5).
Abundances derived from all three omics showed the same data profile. Microbial composition is
affected most by DIO separating along the first component. db/db has the second greatest effect
by separating along the second component. Morphine was shown to have a lesser effect
separating along the third component, but only in the lean mice. These results were corroborated
by hierarchical clustering of 16S and metagenomic data, and analysis of beta-diversity metrics
from the 16S data (Figure 5.6, Figure 5.7).
5.3.3 Differential metaproteomics reveals that taxa-level protein abundances were specific to
sample conditions.
To uncover details behind changes in composition correlated with morphine treatment or
different kinds of obesity, the proteomics data was evaluated for proteins that were significantly
different between conditions. Protein presence versus absence was shown to be the driving effect
in the differential comparison between samples, and these differences appeared to be driven by
the abundance of originating species not the functionality of the organisms. Differential
abundance proteomic analysis revealed 7,324 proteins quantified in all samples from at least
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Figure 5.5: Diet induced obesity alters microbiome composition more than genetic obesity or morphine
treatment. Principle component analysis of log transformed mean centered counts derived from 16S rRNA read
coverage, genome coverage, and metaproteome derived mass spectra assigned to genomes.
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Figure 5.6: Medium quality genomes cluster by experimental group using hierarchical clustering. (A) Scatter
plot of % contamination versus % completion of each genomes as calculated by checkM. Redlines depict a 75%
completion and 5% contamination score. 83% of genomes are above and below that threshold respectively. (B)
Heatmap of normalized inner-quantile of mean coverage per genomes as calculated by Anvi’o. Dendrograms
calculated by ward clustering.
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Figure 5.7: Beta-diversity analysis of mouse 16S data. (A-D) PCoA plots of bray-curitis, unweighted UniFrac,
weighted UniFrac, and Jaccard respectively. (E) Ward clustered heatmap of all the ASV’s collected from colon feces
samples.

one condition. From these, 3,208 were significantly different in abundance between B6 saline
and another condition (Benjamini-Hochberg procedure on student t-test, Q < 0.1). In almost all
cases, a significant protein was present in all three samples of one condition, and absent from all
three samples in one or more other conditions.
Specific species tended to be enriched among proteins abundant in B6 saline relative to
another condition or vice-versa, and these tended to reflect the relative number of proteins
detected for that species in that condition. The pattern of these numbers of proteins aligned with
the genome coverage of that species (Figure 5.8, Figure 5.9). Thus, in a fashion similar to
spectral counting, the number of proteins seem to be a good indicator of abundance for species
biomass (Kleiner et al. 2017). This differential protein analysis suggested that specific species
from the Lachnospiraceae family (labeled Eubacterium sp. or Lachnospiraceae bacterium for
new genera) were suppressed by morphine (only in B6), db/db, and DIO, mice with the most
Lachnospiraceae species suppressed by B6 morphine and DIO (Figure 5.8). This aligned with
random forest classification of the ASV’s, which suggested that high abundance of the
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Lachnospiraceae family was most indicative of B6 saline (Figure 5.10). Previous studies in
which morphine was administered reported similar results (Acharya et al. 2017); however, this
does not mean that all Lachnospiracea bacteria followed this trend. For example,
Lachnospiraceae bacterium 266_1 and Eubacterium sp. 307_1 were more enriched among
proteins more abundant in DIO than in B6 saline. Caution should be employed when making
assumptions about trends relating to broader taxonomic classifications that are driven by specific
species.
5.3.4 Both diet and morphine alter microbiome metabolic functions in specific ways
Since protein enumeration appeared to align to species abundance, it was inferred that
this would apply to functional classifications as well. To explore changes in overall microbial
function between conditions, the number of proteins was tabulated for COG broad functional
categories, KEGG modules/pathways, and KEGG orthologs (Tatusov et al. 2000, Kanehisa et al.
2017). Broad functional classifications were mostly unchanged between individuals, which
aligns with previous literature (The Human Microbiome Project 2012); however, the
carbohydrate metabolism and transport had a significantly lower proportion of proteins in DIO
mice and mice treated with morphine (Figure 5.11). This indicates an overall metabolic effect on
the microbiome due to morphine and high-fat-diet, but not due to genetic obesity. PCA analysis
of normalized number of proteins for KEGG orthologs confirmed the above result for DIO mice
by showing that the DIO mice regardless of treatment were distinct from db/db and B6 mice via
the first principle component, while B6 and db/db mice did not separate along any components
(Figure 5.12). The metabolic shift due to morphine observed at the COG level was not reflected
at the KEGG ortholog level as morphine treated mice, even in B6, were indistinguishable from
saline treated mice by PCA.
To acquire a finer level of detail, KEGG pathways and modules tabulated by number of
proteins per sample were filtered so that each pathway had to have at least 4 proteins detected in
one of its samples. These results were normalized by centered-log-ratio and evaluated by twoway ANOVA comparing the factors mouse line, morphine, and their interactions. Significance
was defined as a Benjamini-Hochburg procedure Q < 0.25.
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Figure 5.8: Differential protein abundance analysis reveals specific Lachnospiraceae species that favor B6 saline
over B6 morphine and different kinds of obesity. (A) Bubble plot of species with at least 15 or more significant
proteins in a comparisons between B6 saline and other experimental conditions. (B-E) Volcano plots of each binary
comparison between B6 saline and another experimental condition. Dotted black lines depict a log2 fold change of
0.5 or greater, and Benjamini Hochberg procedure Q < 0.1 threshold. P-values were calculated by student T-test
only comparing proteins that had at least 3 in one condition. Colors are species specific.
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Figure 5.9: Species enriched for up-regulated proteins align with number proteins and genome sequence coverage of
representative genomes. Boxplots depicting the number of proteins and inner-quantile mean coverage for
representative species from Figure 4.
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Figure 5.10: Random forest classifaction of 16S data show high abundance of Lachnospiraceae to be the best
predictor of B6 saline treated mice.

Three KEGG pathways/modules were significantly different between morphine treated
mice and saline treated mice. The prolactin signaling pathway (ko04917) and the nucleotide
sugar biosynthesis module (M00554) had more protein in saline treated mice then morphine
treated mice, while an ascorbate biosynthesis module (M00129) had significantly more protein in
morphine treated mice relative to saline treated mice (Figure 5.11). Morphine promotes the
production of prolactin (Muraki and Tokunaga 1978); however, the prolactin signaling pathway
had more proteins in saline treated mice relative to morphine treated mice. This result was driven
by microbial orthologs of the protein GaLT (K00965), which is suppressed by prolactin (Figure
5.11) (Halperin et al. 2008). The effect of morphine treatment on GaLT and subsequently the
prolactin signaling pathway appeared driven by the saline treated db/db and B6 mice, but not the
DIO mice. Although not identified by this analysis, KEGG maintains a morphine addiction
pathway, ko05032. This pathway was specified to see if there was a morphine effect, and no
microbial orthologs were found to be associated to this pathway; however, overall there were
more host proteins (P < 0.05) associated with this pathway in morphine treated B6 mice relative
to saline treated B6 mice (Figure 5.11).
Forty- KEGG pathways/modules were found significantly different between mouse lines,
and 31 of these trended similar for db and B6 suggesting that high fat has a greater effect on
microbiome function than genetic obesity. Among these pathways’ pectin degradation, pentose
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and glucuronide interconversions, ascorbate and alderate metabolism, and methanogenesis
pathways all had relatively more proteins in B6 and db/db than in DIO (Figure 5.11).
Conversely, glutathione metabolism, aminobenzoate degradation, fat digestion and absorption,
and thyroid hormone synthesis pathways were all seen to have more relative proteins in DIO
than in db/db and B6.
A similar analysis was conducted for KEGG orthologous groups; however, most of the
significant orthologs were driven by a few proteins detected in one condition and not detected in
another, which is not reflective of a bulk microbiome transition. Despite this, a couple interesting
orthologs stood out. K00383 glutathione reductase was significantly greater in DIO relative to
B6 and db. Expressed by Lactococcus lactis 10_1, among others, glutathione reductase helps
Lactococcus lactis survive oxidative stress (Li et al. 2003), while high fat diet induces oxidative
stress (Du et al. 2012). This could explain why Lactococcus lactis 10_1 is able to thrive in DIO
(Figure 5.8), while overall community richness decreases (Figure 5.3). The large conductance
mechano-sensitive channel, K03282, which protects cells against extreme turgor was the most
significant difference between saline treated mice and morphine treated mice, with more proteins
in morphine treated mice relative to saline treated mice (Figure 5.11) (Levina et al. 1999).
To better observe the larger scale and more robust transitions in microbiome function,
KEGG orthologs (KO) that did not 7 or more proteins in at least one sample were filtered out.
After re-normalization, the majority of significant KEGG orthologs showed differences between
mouse lines (Benjamini-Hochburg procedure Q < 0.25) and had similar trending between db/db
and B6 mice. Several of the KO terms that were significantly up in db/db and B6 relative to DIO
represented enzymes that specifically release sugars from known plant fibers including pectin,
starch, arabinogalactan, and xylan (Figure 5.12). This suggests a preference for plant matter as a
source of nutrients under B6 and db/db conditions as opposed to DIO. Though no clear
pathways, there were a variety of conversion enzymes for the types of sugars that are released
from the above fibers including several enzymes associated with glycolysis, methanogenesis, and
fermentation further suggesting a well-nourished microbiome in B6 and db/db.
In contrast, KO terms with significantly more proteins in DIO mice relative to B6 and/or
db/db mice suggested that high fat diet triggered starvation stress and transitions the microbiome
away from foraging the diet towards foraging the host for nutrients. Trimeric autotransporter
adhesin and flagellar assembly factor, virulence factors involved in host cell invasion and
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Figure 5.11: Counting proteins into functional categories reveals functional shifts between morphine versus saline
and B6/db versus DIO.Boxplots depicting representative broad functional categories, KEGG pathways and modules,
and specific KEGG terms that are significantly different between experimental conditions after the first filtration. At
the top the broad COG category G represents the relative proportion of proteins that belong to that category. For the
KEGG orthologs K00965 and K02382 these are the centered-log-ratio of tabulated proteins after filtering out all KO
terms that did not have 4 proteins in at least one samples. The remaining boxplots represent KEGG pathways or
modules, which also had their proteins tabulated and normalized by centered-log-ratio after filtering any pathways
or modules that did not have at least 4 proteins in at least one sample. All p-values are from TukeyHSD after twoway ANOVA
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Figure 5.12: Counting proteins into KEGG orthologs reveals diet fiber degrading enzymes are more present in db
and B6 than DIO. Number of quantified proteins per sampler were counted for each KEGG ortholog group. Kegg
orthologs that had less 7 proteins max in a sample were filtered out. The remaining KEGG orthologs were
normalized by center log ratio. All P-values are calculated by TukeyHSD after two-way ANOVA. All enzymes pass
a Benjamini Hochberg procedure Q < 0.25. Starting at the top principle component analysis reveals that DIO has a
distinct functional profile from db and B6, while B6 and db are overall indistinguishable. Boxplots depict specific
KEGG Orthologs that degrade starch, xylan, arabinogalactan, or pectin and have significantly more normalized
proteins in db and B6 than DIO.

adherence to components of the extracellular matrix such as glycoproteins (Müller et al. 2011,
Haiko and Westerlund-Wikström 2013), as well as SpoIIIAA, a protein critical for initiation of
sporulation (Kellner et al. 1996), each had significantly more normalized proteins in DIO than
db/db mice and/or B6 mice. Many orthologs with more proteins in DIO came from the KEGG
amino sugar and nucleotide sugar pathway, which contains enzymes that catalyze fucose,
acetylneuraminate, and acetylglucosamine (Figure 5.13). Mucins are glycoproteins that make up
a major portion of the intestinal mucosal layer, and mucins’ serine and threonine residues
connect to glycans made up of fucose, acetylneuraminate, and acetylglucosamine, along with
acetylgalactosamine and galactose (Holmen Larsson et al. 2013). Acetylgalactosamine and
galactose catalyzing enzymes, however, were not significantly different between mouse lines,
which may suggest that those enzymes are not well annotated or that the high fat diet
microbiome prefers fucose, acetylneuraminate, or acetylglucosamine as sources of nutrition.
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It is known that several glycoside hydrolases, hexosaminidase, fucosidase, galactosidase,
and sialidase, specifically release the different components of mucin glycans (Marcobal et al.
2013). Galactosidases, though present, did not appear to have different abundances between
conditions; however, a sialidase ortholog, K01186, and a fucosidase ortholog, K01206, each had
more normalized proteins in DIO versus B6 or db/db, respectively (by P < 0.05 but not by
Benjamini-Hochberg procedure), supporting the fucose and acetylneuraminate catalyzing
enzymes that were up in DIO. The hexosaminidase KEGG ortholog K12373, however, did have
significantly more normalized protein in DIO relative to B6 and db/db, and is specifically
annotated to release acetylglucosamine from glycans. Additionally, the chitinase ortholog
K01183, which is also annotated to release acetylglucosamine from glycans, specifically chitin,
had significantly more protein in DIO and db/db relative to B6. Although there is no known
chitin in mammalian guts, it has been shown that chitin may be an evolutionary precursor to
mucin (Nakashima et al. 2018), and bacterial chitinase when combined with proteases has been
shown to have mucolytic properties (Sanders et al. 2007). The xaa-pro dipeptidase ortholog
K01271, initially isolated from guinea-pig intestinal mucous (O'Cuinn and Fottrell 1975), was
found to have significantly more normalized protein in DIO and db/db mice than B6 mice
providing the protease for the chitinase.
Using KEGG data surrounding the KEGG amino sugar and nucleotide sugar pathway,
a new pathway from mucin to fructose-6-phosphate via acetylglucosamine was proposed (Figure
5.13). This pathway proposes the release of acetylglucosamine from mucin via chitinase,
hexosaminidase, and xaa-pro dipeptidase orthologs, followed by the import of acetylglucosamine
into the cell by phosphotransferase system orthologs, the deacetylation of now
acetylglucosamine-6-phospate by N-acetylglucosamine-6-phosphate deacetylase orthologs, and
the conversion of glucosamine-6-phosphate to fructose-6-phospate by glucosamine 6-phosphate
deaminase orthologs. The evidence for all of these orthologs came from many different species
across the different samples, and all these orthologs had higher relative protein in DIO versus
db/db and/or B6.
Some elements of this pathway require some qualification. The traditional
phosphotransferase system (PTS) for acetylglucosamine was not significantly different in
abundance; however, the mannose PTS system EIIAB component, shown to import
acetylglucosamine into microbial cells, was significantly more abundant in DIO relative B6 and
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Figure 5.13: Counting number of proteins in KEGG orthologs reveals a complete pathway from mucus to DFructose 6-phosphate that is more abundant in DIO than B6 or db. (A) Boxplots supporting the notion that high fat
drives the microbiome towards starvation stress and degradation of mucin. (B) Proposed pathway from mucin to
fructose-6-phosphate. (C) Specific KEGG orthologs supporting the pathway. Here KEGG orthologs were filtered
out if they did not have 7 proteins in at least one sample. Then they were normalized by centered-log-ration. Finally
p-values were calculated by TukeyHSD following two-way ANOVA.
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db/db (Moye et al. 2014). Glucosamine 6-phosphate deaminase, the final step of the pathway,
was not significant by Benjamini-Hochberg procedure, but was by P-value (P=0.01).
Increased forging of the host mucosal layer due to poor nutritional diets has been shown
for low fiber and westernized diet in several studies (Desai et al. 2016, Schroeder et al. 2018).
Though it has been suggested that the capacity for mucosal foraging may be widespread, these
studies for the most part are species driven, and specifically Bacteroidetes thetaiotamicron and
Akkermansia muciniphila have been shown to forage the mucosal layer for nutrients
(Sonnenburg et al. 2005, Berry et al. 2013). Both Bacteroidetes thetaiotamicron and
Akkermansia muciniphila were detected in this study, and several of the orthologs described
above were detected for these species, but they were not the primary driving factor for the
observation that high fat diet drives the microbiome towards host foraging. An important
component of the pathway described above was that it included the incorporation of free
acetylglucosamine into the cell prior to being incorporated into the central metabolism via
glycolysis. This suggests that acetylglucosamine could be cleaved from mucus by one species
and used for energy by another. These results suggest that transition towards host foraging is not
driven by any one species but instead by a bulk microbiome concerted effort.

5.4 Discussion
This study sought to compare the effects of morphine on the composition and function of
the gut microbiome in the context of two different kinds of obesity. Although a few studies have
observed morphine to have a significant impact on the composition of the gut microbiome
(Acharya et al. 2017, Wang et al. 2018), the authors are not aware of any studies that have done
so in the context of obesity or have examined how morphine changes the functionality of gut
microbiota. In this study, high-fat-diet disrupted the gut microbiome’s composition by a greater
magnitude than morphine or genetic obesity, as evidenced by hierarchical clustering and
principle component analysis of taxonomic features independently quantified and analyzed from
16S, metagenomic, and metaproteomic data. Supported by multiple lines of evidence, the already
disturbed microbiome in db/db and DIO mice masks the morphine effect, implying that more
mild perturbations of the gut microbiome may not be observable when the microbiome has
already been disturbed.
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As previously observed, specific Lachnospiracea species appeared to be suppressed by
morphine and the cytokine IL-6 was more abundant in morphine treated B6 mice relative to
saline treated B6 mice (Acharya et al. 2017). Unlike previous observations, Enterococcus was
not observed to be significantly more abundant in morphine treated mice regardless of line
(Wang et al. 2018). Studies have shown that the overall composition of the microbiome varies
substantially by individual (Ley et al. 2005, The Human Microbiome Project 2012, BlakeleyRuiz et al. 2019), which can help to explain why specific taxa may not shift in abundance due to
the same perturbation across studies where the starting composition the microbiome might be
quite different. The message here is that morphine does indeed seem to alter the gut microbiome
composition in a consistent manner within this study, though shifted by a lower magnitude
relative to the dramatic shift induced by high-fat diet.
Functionally, morphine appeared to suppress microbial carbohydrate metabolism;
however, this effect was only observed at the broad category level not between KEGG orthologs
as no samples separated due to morphine treatment in principle component analysis of tabulated
KEGG orthologs. Nevertheless, the presence of morphine did appear to suppress or promote
proteins of a few host and microbial pathways/orthologs. In particular, the KEGG Prolactin
pathway had significantly more proteins in saline treated mice than in morphine treated mice.
This was primarily driven by microbial orthologs of the host protein GaLT. Host GaLT is
suppressed by prolactin in its short form (Halperin et al. 2008), and prolactin is known to be
increased by morphine treatment (Muraki and Tokunaga 1978). This suggests host hormones
may also sometimes suppress the microbial orthologs of their host targets. The KEGG ortholog
most significantly affected by morphine was the large conductance mechano-sensitive channel,
K03282, which protects cells against extreme turgor (Levina et al. 1999). One of the side effects
of morphine is increased urinary retention, which in extreme cases can lead to low serum
osmolality (hyponatremia), a decrease in serum sodium concentration leading to an excess water
relative to solute (Petersen et al. 1982, Petros et al. 1993, Langfeldt and Cooley 2003). This
along with the prolactin results suggests that known impacts of morphine on the host may affect
microbial functionality as well; however, it seems that this did not manifest in any overall shifts
similar to those observed in the compositional analyses. This implies that morphine may have an
even more mild effect on microbial function than it does on microbial composition.
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A couple of studies have shown high-fat-diet induced obesity to have a greater magnitude
effect on microbiome composition than genetically induced obesity (Carmody et al. 2015,
Pfalzer et al. 2015). The data from this study supports this assertion by beta-diversity analyses,
principle component analyses, and hierarchical clustering in all three of the major omics
measured. Furthermore, different species were either suppressed or promoted by high-fat diet or
diet induced obesity relative to lean mice. Further supporting the notion that genetic obesity
changes the composition of the gut microbiome distinctly from high fat diet.
A few studies have used metaproteomics to explore the effects of obesity on the
microbiome (Ferrer et al. 2013, Kolmeder et al. 2015, Zhang et al. 2016, Guirro et al. 2018). To
the authors knowledge, however, no study has looked at effects of different kinds of obesity on
microbial function from a proteomics perspective. In this study, principle component analysis of
KEGG orthologous groups indicated that genetic obese mice and lean mice were
indistinguishable, while high-fat-diet clearly separated along the first component implying a
change in microbial function due to high-fat-diet not obesity itself. Supporting this interpretation,
in most cases, KEGG orthologs marked as significantly different between lines were not
significantly different between db and B6, but were different in DIO relative B6 to db. This high
fat diet induced change in microbial metabolic function manifested as a decrease in dietary fiber
degrading enzymes, and an increase in mucin metabolizing enzymes. High-fat-diet decreases
availability of nutrients favored by the microbiome in exchange for fat. This dearth of
carbohydrates could lead to starvation induced stress and push gut microbes toward foraging the
mucosal layer for sugar. Previous studies have suggested a transition to nutrient foraging from
the host mucosal layer due to poor diet with different methods, but those studies have been
species focused (Sonnenburg et al. 2005, Berry et al. 2013, Desai et al. 2016, Schroeder et al.
2018). A novel aspect of the presented result is evidence that this transition was not driven by a
specific subgroup of species, but by a variety of species from different phylogenetic groupings.
For example, 43, 47, 71, and 97 distinct species had protein evidence for hexosaminidase,
chitinase, n-acetylglucosamine-6-phosphate deacetylase, and glucosamine 6-phosphate
deaminase, respectively, indicating community, not species, driven transitions in function. This
functional shift would not be visible when focusing on individual proteins or species instead of
community function.
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The previous metaproteomic obesity studies did not identify any bulk microbiome shifts
in metabolic function. Some studies did notice increases in flagellar complexes and other
adhesion related proteins and surmised that this was related to an increase in adhesion to the host
extracellular matrix (Ferrer et al. 2013); however, they did not capture that the reason was to
degrade mucin. Multiple factors could have contributed to this, including a shallow measured
metaproteome (Ferrer et al. 2013), too broad functional classification (Kolmeder et al. 2015,
Zhang et al. 2016), ambiguity caused by using BMI as a delimiter (Ferrer et al. 2013, Kolmeder
et al. 2015), or splitting the functional analysis between taxa (Guirro et al. 2018). Instead these
studies focused substantial effort towards the previously mentioned Firmicutes/Bacteroidetes
ratio, ultimately producing conflicting results. In the current study, there were no phyla that were
statistically different in relative abundance between conditions. Since the beta-diversity analysis
implied specific organisms were more important than phylogenetic groupings, no further effort
was given to this topic. Bacteroides thetaiotaomicron, a Bacteroidetes, and Eubacterium sp.
307_1, a Firmicute, were found to favor high fat diet over lean. Conversely, Muribaculaceae
bacterium 79_1, a Bacteroidetes, and Eubacterium sp. 230_1, a Firmicute, favored lean over
high fat diet. While early studies seemed to find that more Bacteroidetes and less Firmicutes
were indicative of a healthy gut (Ley et al. 2005, Turnbaugh et al. 2009), this connection does
not seem to hold up in recent studies (Finucane et al. 2014, Walters et al. 2014). Perturbations
affect bacterial species, not their phylogenetic groupings.
Despite the existence of mouse microbiome gene catalog(Xiao et al. 2015), and numerous
studies exploring the gut microbiome of mice (Ley et al. 2005, Turnbaugh et al. 2008, Zhang et
al. 2016), this study found that the majority of genes detected by metagenomic/metaproteomic
analysis came from novel species not represented in the NCBI or UniProt repositories. This
agrees with recent publications suggesting thousands of new bacterial species continue to be
uncovered by metagenomics, even in systems considered to be well defined (Brown et al. 2015,
Parks et al. 2017, Pasolli et al. 2019). This highlights the importance of continuing to sequence
metagenomic samples even in types of environments that are well studied as it seems that there is
still more sequence space to uncover. Thus, highlighting the importance of sequencing DNA
from new environmental samples prior to metaproteomic analysis. Although it is possible to
detect peptides from reference databases using relatively any sample, those identifications can be
entirely erroneous if the proteins present in the sample are not represented in the database
110

(Timmins-Schiffman et al. 2017). In the hope that the mouse microbiome will be better covered
in public repositories in the future, this study has contributed all genomes and their respective
proteins to GenBank.
The objective of this study was to uncover differences in gut microbiome composition
and function due to morphine treatment in the context of genetic or high-fat-diet induced obesity.
Towards that end, this study found several changes in microbial composition that were consistent
with previous studies. Furthermore, this study showed that an observable change in microbial
composition does not necessarily translate to an observable change in microbiome function.
While morphine, genetic obesity, and high-fat-diet were all shown to have a significant impact
on total microbial composition, a discernable functional shift was only observable for high-fatdiet when considering KEGG orthologs. Ultimately, this study shows that caution should be
employed when attributing a microbiome change to specific taxonomic features. This study
highlights the importance of looking at microbiome function concurrently with taxonomic
composition. Gut microbiomes can be quite varied between individuals regardless of physiology,
microbiome functionality tends to be more stable (The Human Microbiome Project 2012)
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6

CONCLUSIONS AND PERSPECTIVES ON METAPROTEOMICS
RESEARCH
The goal of this dissertation was to advance gut microbiome research by examining how

to analyze changes in metabolic function using metaproteomics data. The first step in this
process was to identify a framework by which differences between experimental conditions
could be analyzed. In chapter 3, multiple fecal samples taken from five adult individuals
throughout a year were measured using metaproteomics. The goal was to investigate the stability
of gut metaproteomes across time and individuals. These metaproteomes were highly variable
between individuals. Only seven microbial proteins were identified across all samples, and even
within an individual as few as 7% of the proteins were identified across all samples collected
from that individual. This variation in proteins detected presented an intractable analysis
problem. How could the metaproteomes between samples be compared quantitatively with so
few common features?
KEGG orthologs were found to be more likely to be shared between samples across time
than protein groups, suggesting a better space for comparison between samples. Using the
KEGG orthologs to infer gut-specific metabolic modules, paths from carbohydrate and amino
acid degradation to short-chain fatty acid production were shown to be present across all
samples. These paths were multi-phyletic and different phyla across time, and individuals would
drive these metabolic modules while the function persisted. This result suggested that the
metabolic modules were not driven by any specific phyla but by the microbial community as a
whole. Detailed inspection of the component KEGG orthologs of these modules led to the
observation that a network of enzymatic reactions linked together by the reactants and products
underpinned these metabolic modules. This observation led to the hypothesis that, guided by
metaproteomics, metabolic networks could be used to analyze a gut microbiome’s metabolic
function independent of preconceived pathways and modules.
In Chapter 4, this hypothesis was tested using a gut metaproteome collected from preterm
infants that was recently published as part of a collaboration between the Hettich, Banfield, and
Morowitz groups (Xiong et al. 2017, Brown et al. 2018). This metaproteome had several
advantages over the previous data set. It remains one of the deepest metaproteomes collected to
date, allowing for a more comprehensive representation of microbial metabolism. This
metaproteome was underpinned by a thorough effort in genome resolved metagenomics,
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allowing proteins to be traced back to their genus, species, or even subspecies of origin. The
preterm infant gut microbiome is of lower complexity than the adult gut microbiome, allowing
for a more comprehensive view of gut microbiome function. Finally, this study had two
experimental groups, allowing for metabolic function to be quantitatively compared between
conditions.
In Chapter 4, the proteins detected were quite distinct between samples; however, the
reactions that these proteins coded for were much more conserved between samples.
Interestingly, reactions were also more conserved than the KEGG orthologs that derived the
reactions implying that the specific function was more conserved across samples than the
orthologous groupings. These reactions could be linked together by the compounds they catalyze
to form mostly connected metabolic networks even after the removal of currency metabolites.
Using information from the metaproteome, it was possible to distinguish between reactions that
were from the host, the microbiome, or shared between the microbiome and the host, providing a
framework for analyzing host and microbiome functionality concurrently. Mixed-effects
modeling uncovered metabolic groupings of reactions from both the host and the microbiome
that differentiated infants that developed necrotizing enterocolitis from those that did not. This
analysis uncovered a pathway from chorismate to the siderophore enterochelin, confirming that
key pathways could be uncovered using the compound to reaction data present in KEGG.
Predefined KEGG pathways and modules were still indispensable in providing them with
biological context.
In Chapter 5, all the technical concepts discussed in the previous chapters were applied to
a new system, the mouse gut microbiome. In this chapter, the goal was to examine the effects of
morphine on two different types of obesity using an integrated metagenomics/metaproteomics
approach. Genome resolved metagenomics revealed the species uncovered from these mice to be
underrepresented in NCBI and other public repositories. This result validated the suspicion that
concurrent metagenomic and metaproteomic measurements were necessary for the
metaproteomics analysis. Differential protein abundance analysis found that significant
differences in protein abundance were more indicative of changes in taxonomical abundance
than function. Thus, perturbations of microbial function were instead analyzed by quantifying
KEGG reactions and KEGG orthologs. Reactions significantly different between conditions
could all be found among the significantly different KEGG orthologs, while KEGG orthologs
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also covered functions like transportation and sporulation. In this analysis, predefined KEGG
pathways and modules were indispensable for inferring the underlying biological meaning of the
over or under represented KEGG orthologs. Regardless, a new pathway degrading mucin into
fructose-6-phosphate via acetylglucosamine was proposed using compound to reaction data. This
pathway could not have been uncovered without further inspection beyond the predefined KEGG
pathway information.
Chapter 5 showed that at the taxonomical level, the diet induced obesity gut microbiome
was as distinct from the genetic obesity gut microbiome as it was from the lean gut microbiome.
Morphine had a detectable effect on the lean mouse gut microbiome that was not observed in the
obese mice. The above effects were, for the most part, masked at the functional level, and only
the differences caused by diet-induced obesity were particularly striking as a high in fat diet
triggered a shift in metabolic sources of sugar.
Ultimately, these chapters provide a framework by which the microbiome, in general, can
be compared functionally. Using annotations from KEGG or other databases that contain
identifiers for specific biological functions, shifts in specific functions could be compared
between experimental conditions using metaproteomic data. These shifts in function could be
traced back to their species or even subspecies of origin using genome resolved metagenomic
data. More often than not, tracing functions back to species of origin showed different species
performing the same function across time and individuals confirming the need to look at shifts in
microbiome function concurrent with taxonomical differences.

6.1 Getting a deeper metaproteome
When this dissertation commenced, state-of-the-art for metaproteomics was to detect a
few thousand proteins per sample, as exemplified by chapter 3. This was a significant feat driven
by the availability of concurrent metagenomes with metaproteomes, high mass accuracy
instruments, and chromatography. As this dissertation work progressed, these numbers were
improved by an order of magnitude to greater than ten thousand proteins per sample. The
original analysis of the preterm infant metaproteomics data reported no more than 6,000 proteins
per sample. After re-analysis, the same data reported tens of thousands of proteins per sample.
This was driven by a couple of adjustments in how the raw data was processed. Combining
multiple metagenomes from the same study instead of just searching against the sample-specific
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metagenome yielded an increase in the number of distinct peptides detected per sample, as
shown in Figure 2.7. A manuscript published by the Noble lab indicated that calculating the
exact p-value as a scoring metric during database searching and combining that with other
scoring metrics yielded a higher number of peptides passing the FDR threshold (Howbert and
Noble 2014). Finally, the criteria of one unique peptide and at least two different peptides
decreased the number of proteins detected by greater than three quarters, without a comparable
improvement in FDR, essentially making this criterion too conservative. Together these
adjustments led to tens of thousands of proteins detected per sample.
Even so, metaproteomics remains far from the comprehensive detection of proteins in gut
microbiomes. Ten thousand proteins detected is only about one to three percent of the proteins
predicted by a typical metagenome. While it is fair to assume that not all predicted genes will be
expressed as proteins, most predictions assume that there are at least 100,000 to 200,000 distinct
proteins in an adult fecal sample at any given time, meaning that metaproteomics still needs to
improve by an order of magnitude to achieve comprehensive measurement (Zhang and Figeys
2019). In 16S rRNA sequencing, a rarefaction curve is typically used to show that the microbial
community has been adequately sampled. Usually, it takes two orders of magnitude more
sequences measured than there are amplicon sequence variants to saturate the measurement. In
contrast, a typical metaproteomics measurement currently has no more than 200,000 scans
measured in total per sample, and never more than 1 million. To the author's knowledge, no
study has attempted to measure 1 million let alone 10 million spectra per sample. An interesting
approach would be to use metagenomics to first predict how many proteins need to be detected
to comprehensively measure a metaproteome, and then proceed to measure two orders of
magnitude more spectra than that number to see if that number can be matched. It should be
noted that metaproteomics is, in many ways, an inherently different measurement than
sequencing. Sequences are detected via random sampling, while peptides are separated over time
and detected in a data dependent manner, thus providing a more systematic albeit still somewhat
stochastic sampling. Thus, assumptions about the amount of sampling needed to achieve the
same dynamic range in protein measurements versus sequencing measurements may not align
one to one. It is still reasonable, however, to assume that if one wants to measure a
comprehensive proteome, one should have several times more scans than the number of proteins
one expects to detect.
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6.2 Modeling gut microbiome metabolism
Microbiome research is reaching the point where the next phase is to be able to
comprehensively observe shifts in microbial metabolism over time and across perturbations. One
proposal to do this is to create genome-scale metabolic models of the constituent organisms in a
microbial community (Magnúsdóttir et al. 2017). The problem with this approach is that it
cannot handle the dynamic aspects of the microbiome. No matter how many genome-scale
metabolic models are produced, a different set of species will be present in the next individual. A
good genome-scale models account for all the genes in a genome. However, it is already
expected that all the genes will not be expressed at any given time and that there might be
substantial function shared across a gut microbiome, as observed in Chapter 4. Others have
suggested using metaproteomics to create context-specific metabolic network reconstructions
based on metaproteomics information (Tobalina et al. 2015). This was performed in Chapter 4
yielding mostly connected sample-specific metabolic networks across 91 samples. Thus, the field
is within striking distance of metaproteomics guided metabolic network reconstruction followed
by metabolic modeling.
Chapter 4 provides a proof of principle for metabolic network reconstruction, but not for
metaproteomics guided metabolic modeling. To achieve this, a more constrained community is
ideal where the sources of carbon are well-controlled, the entire community is well-defined with
complete genomes, and the community does not change in composition over time. Two options
for this could be gnotobiotic mice with defined communities or gutless worms with well-known
symbionts (Ridaura et al. 2013, Kleiner et al. 2018).
To achieve metaproteomics guided metabolic modeling, a few things are needed. A
method for estimating the comprehensiveness of a metaproteomic measurement. A method for
controlling the carbon sources of the microbial community so that a flux balancing analyzing
analysis can be done. An adjustment to the flux balancing analysis that does not necessarily
assume that all the bacteria are continuously increasing in biomass. A method for dynamic
compartmentalization of the metabolic network by species. Achieving these needs, however,
requires several advances in the field of microbial ecology.
To date, it is not known what percentage of a microbe's genome is expected to be
expressed in a community setting. Using defined microbial communities, this could be explored
by measuring combined isolates from a community and then the community itself using the same
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mass spectrometry approach. This could inform whether the percentage of the proteome from
each species detected is driven by the measurement or by a change in the percentage of the
proteome that is being used in isolation versus a community setting. Mammals consume a
complex diet with multiple carbon sources that could be utilized by different bacteria. Stable
isotope fingerprinting and stable isotope labeling are methods by which the carbon source for
constituent members of the microbiome can be predicted (Kleiner et al. 2018). Applying this
method to a microbial community with a defined diet could aid in the construction of a carbon
source medium for a flux balance analysis. The Banfield group has developed a method for
predicting the replication rate of bacteria based on the sequencing coverage information of a
genome (Brown et al. 2016). This method could be used to determine which bacteria in a
community are increasing in biomass versus which bacteria are merely surviving. This could
provide a guide for both the compartmentalization of bacteria and for the parameters of a flux
balance analysis.

6.3 Final thoughts
It is an exciting time to be studying microbial ecology. Despite tremendous funding
initiatives over the last two decades, there is still a lot to learn. In a simple example, if one were
to sequence the soil samples from all the trees at the University of Tennessee, many new
microbial species would likely be uncovered. The microbiome research community is just
beginning to uncover the vast amount of microbial diversity that is out there (Parks et al. 2017,
Pasolli et al. 2019). The tools that enable these kinds of analyses are now mature enough that
anyone familiar with the Unix command line and access to the internet can implement them.
Beyond sequencing, much remains to be understood about how microbial communities function.
For example, what percentage of a microbe’s genome is expressed in a community setting versus
when grown in isolation and to what degree do microbes share metabolites in community
settings. Metaproteomics is a powerful tool to answer these pertinent questions. Already it has
been shown that as much as 45% of the proteins in a microbe's genome can be detected in a
metaproteomics study (Xiong et al. 2017); however, it remains to be determined whether the
remaining species in the community are merely not expressing as many genes as that species or
if there an issue with the limit of detection of the mass spectrometry measurement. Resolving
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this issue will lead to comprehensive metaproteomic profiling, uncovering the degree to which
microbes share metabolic functions.
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